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Abstract
Apolipoprotein L-1 (APOL1) is a secreted protein that provides protection
against several protozoan parasites due to its channel forming properties. Recently
evolved variants, G1 and G2, increase kidney disease risk when present in two
copies. In mammalian cells, overexpression of G1 and G2, but not wild-type G0, leads
to swelling and eventual lysis. However, the mechanism of cell death remains
elusive with multiple pathways being invoked, such as autophagic cell death
mediated by a BH3 domain in APOL1, which we evaluated in this study. We
hypothesized that the common trigger for these pathways is the APOL1 cation
channel, which is pH-gated and requires acidification followed by neutralization to
function, conditions met along the secretory pathway. Testing ion selectivity in
planar lipid bilayers revealed that all APOL1 variants conduct Ca2+. Furthermore, we
discovered that cellular toxicity of G1 and G2 was Ca2+-dependent and led to a
cytosolic Ca2+ influx, without ER Ca2+ release, quantified via high-throughput livecell microscopy. This influx preceded swelling and required prior plasma membrane
(PM) localization, demonstrated by expression of tagged APOL1 in the Retention
Using Selective Hooks system. G0 was also cytotoxic if acidified and neutralized after
PM localization, suggesting regulation along the secretory pathway that G1 and G2
evade. Furthermore, we report that PM wound repair mediated by ESCRT-III
promotes cell survival against APOL1 cytotoxicity, and that the putative BH3
domain is dispensable for APOL1-mediated cell death. These results indicate that
APOL1 channel activity drives cytotoxicity via Ca2+ influx, and as a potent signaling
molecule, Ca2+ may activate previously reported cell death pathways.
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Background
The APOL Gene Family
Apolipoprotein L-1 (APOL1) is a primate-specific innate immunity gene
(Smith and Malik, 2009) that encodes for a cation channel (del Pilar Molina-Portela
et al., 2005; Thomson and Finkelstein, 2015). It is part of the rapidly evolving APOL
family, containing genes APOL1-6, which reside in a 620kb region of chromosome.
APOL5-6 are the oldest genes in the family, while APOL1-4 are primate-specific and
arose through duplications beginning ~33 million years ago. The region has
undergone heavy positive selection during primate evolution (Smith and Malik,
2009), and as all APOL genes are induced by pro-inflammatory cytokines (Liao et al.,
2011; Nichols et al., 2015; Schoggins et al., 2014; Zhaorigetu et al., 2011) ,this
signifies a role in the host immune system. Indeed, the pro-apoptotic APOL6
provides immunity against Poliovirus (Schoggins et al., 2014), and APOL1 is
associated with lowering HIV infectivity in HEK293 cells (Taylor et al., 2014). It is
suspected that the immunity provided by these genes is due to their roles in
promoting or inhibiting programmed cell death pathways (Liao et al., 2011; Wan et
al., 2008; Zhaorigetu et al., 2011), however this remains controversial. Importantly,
APOL1 provides immunity independent of programmed cell death pathways.

APOL1 Provides Immunity Against African Trypanosomes
APOL1 is unique among the APOL family members because the major splice
isoform encodes a signal peptide for protein secretion (Monajemi et al., 2002). Upon
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secretion, APOL1 associates with specialized high-density lipoprotein (HDL)
particles termed trypanosome lytic factors (TLF) 1 and 2 (Barth, 1989; Lugli et al.,
2004; Raper et al., 1999). The structure of the APOL1 associated with HDL particles
is unknown, but based on other lipoproteins it is presumed that the amphipathic
helices are embedded into the face of the phospholipids that form the surface of the
HDL and that each APOL1 is a monomer. TLFs continuously circulate within the
bloodstream and make up approximately 1% of total HDLs. TLF1 and 2 also contain
proteins apolipoprotein A-I (APOAI), the essential structural component for all
HDLs, and haptoglobin-related protein (Hpr). Additionally, TLF2 is associated with
an immunoglobulin M (IgM) molecule (Lugli et al., 2004; Raper et al., 1999).
Circulating continuously within the bloodstream, TLFs provide an innate defense
against leishmania (Samanovic et al., 2009) and African trypanosome parasites
(Hager et al., 1994), of which Trypanosoma brucei is the most studied.
African trypanosomes are single-celled, flagellated, protozoan parasites that
have a two-species life cycle between mammals and the tsetse fly vector. After
delivery via the tsetse fly, trypanosomes circulate in the bloodstream of the
mammalian host and can eventually cross the blood-brain barrier causing sleeping
sickness, which is fatal. They evade the adaptive immune system due to a dense coat
of variant surface glycoprotein (VSG) that surrounds their plasma membrane (PM),
blocking access to other epitopes (Barry and McCulloch, 2001). One VSG gene is
expressed at a time, and is switched stochastically every 1/1000 divisions (Turner,
1997). As the adaptive immune system responds to the first VSG detected, several
other populations will have arisen expressing other VSGs (Mugnier et al., 2015), in a
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perpetual game of cat and mouse in which the trypanosomes almost always win.
However, humans and some primates (Lugli et al., 2004) are resistant to nearly all
species of African trypanosome due to the action of the innate immunity complexes
of TLF (Hajduk et al., 1989; Vanhamme et al., 2003).
TLF immunity against trypanosomes is due to uptake of the complex by the
parasite (Hager et al., 1994; Hajduk et al., 1989). Trypanosomes are hemeauxotrophs (Berriman et al., 2005; Kořený et al., 2010) and therefore scavenge it
from the mammalian host. Free hemoglobin (Hb) is sequestered by haptoglobin
(Hp) (Andersen et al., 2012) to prevent oxidative damage, and is recognized by the
host CD163 receptor for bloodstream clearance (Nielsen et al., 2006; Schaer et al.,
2006). Trypanosomes express a very different haptoglobin-hemoglobin receptor
(HpHbR) to endocytose these Hp-Hb complexes (Higgins et al., 2013; Stødkilde et al.,
2014). Taking advantage of this, the TLF-specific Hpr also binds Hb and is
recognized by HpHbR (Drain et al., 2001), but not CD163 (Drain et al., 2001; Nielsen
et al., 2006). This allows for endocytosis of TLF1 by the parasite, though this
endocytosis can be inhibited by normal levels (0.25-1 mg/ml) of HpHb (Smith and
Hajduk, 1995). Entry of TLF2 occurs independent of HpHbR, as unlike TLF1 it can
lyse HpHbR-null parasites (Vanhollebeke et al., 2008). However, the “receptor” for
the enhanced uptake of TLF2 remains undefined. Once endocytosed, both TLFs
deliver the killing blow of APOL1.

APOL1 Kills Trypanosomes by Forming pH-gated Cation-Selective
Channels
3

Trypanolysis by TLF is due to APOL1 and its channel forming properties
(Thomson and Finkelstein, 2015). Contention between whether APOL1 or Hpr were
the lytic component of TLF was settled with the discovery of a human patient that
was infected with T. evansi, which normally infects domesticated mammals. The
patient had frameshift mutations in both APOL1 alleles, and his non-trypanolytic
serum could be restored with addition of r recombinant APOL1 (rAPOL1)
(Vanhollebeke et al., 2006). Additionally, mice infected with T. brucei could be
protected by hydrodynamic gene delivery (HGD) of an APOL1-containing plasmid,
which would be expressed in the liver and secreted onto HDLs. Expression of Hpr
did not protect mice from infection, leading to the conclusion that APOL1 is the lytic
component of TLF (Molina-Portela et al., 2008).
APOL1 channel formation is a two-step process: First, acidification is
required for an irreversible insertion into membrane, followed by neutralization for
channel opening. Incubation of recombinant APOL1 (rAPOL1) in a planar lipid
bilayer at neutral pH did not lead to channel formation and allowed rAPOL1 to be
perfused away, indicating weak or no association with the membrane (Thomson
and Finkelstein, 2015). However, incubation at pH 5.5 led to the recording of a small
current with both rAPOL1 and TLF1 (del Pilar Molina-Portela et al., 2005; Thomson
and Finkelstein, 2015). This current was thought to represent APOL1 channel
activity, however subsequent experimentation with rAPOL1 revealed that this was
likely due to membrane insertion, which caused a small ion leak (1-2pA).
Neutralization of rAPOL1 after acidic insertion caused a 100-200-fold increase in
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current, indicating that the channel is pH-gated and in an open state in a neutral
environment.
The requirement for pre-acidification is likely to drive oligomerization. The
C-terminus of APOL1 contains a leucine zipper domain (Vanhollebeke and Pays,
2006) that may drive homo-oligomerization (Baisamy et al., 2005). This region
contains an isoelectric point (pI) of 4.5-5.0, indicating that acidification could allow
for irreversible membrane insertion due to neutralization of the charges. In
contrast, baboon APOL1 does not require acidification for channel formation
(Thomson, 2018), and the pI of the C-terminus is approximately 9.0-9.5 (Thomson
et al., 2009). This suggests that for channel assembly, the acidification of human
APOL1 drives membrane insertion of the C-terminus.
Ion selectivity experiments revealed that the APOL1 channel is selective for
monovalent cations Na+ and K+, but not for Cl- (Thomson and Finkelstein, 2015).
Delivery of APOL1 into trypanosomes causes an influx of Na+ (del Pilar MolinaPortela et al., 2005). In response to an increase of positive charges in the cytoplasm,
and possible membrane depolarization, a K+ efflux occurs. This drives both an influx
of Cl- and water, the latter due to the increased amount of solutes in the cytoplasm,
and leads to osmotic swelling and lysis (Rifkin, 1984). Replacement of Na+ in the
media with larger, APOL1-impermeable cations such as choline, led to partial rescue
of trypanosome lysis from TLF (del Pilar Molina-Portela et al., 2005). Furthermore,
incubation of trypanosomes with osmotically active sucrose delayed lysis by human
serum (Rifkin, 1984). APOL1 channel formation also requires acidification in
trypanosomes, as pre-treatment with weak bases (Hager et al., 1994; Thomson and
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Finkelstein, 2015) or RNAi knockdown of the vacuolar-ATPase (Currier et al., 2018;
Lecordier et al., 2014) blocked or diminished the lytic activity of TLF, respectively.
These data lead to a proposed model of trypanolysis wherein APOL1 (within TLF) is
acidified after endocytosis, allowing for membrane insertion, followed by recycling
to the PM where the cation selective channel opens. This model is contentious,
however, as others have proposed the lysosome or the mitochondria as the site of
APOL1 trypanolytic activity. (Perez-Morga et al., 2005; Vanwalleghem et al., 2015)
Importantly, studies providing these alternative hypotheses have performed their
experiments with rAPOL1, which does not occur naturally. A recent RNAi screen in
trypanosomes that probed for genes that affected trypanosome survival in response
to APOL1 discovered that treatment with TLF1 and rAPOL1 lyse trypanosomes via
different mechanisms. Chiefly, the kinesin required for rAPOL1 toxicity linked to the
mitochondria had little to no effect on the lytic activity of the physiologically
relevant TLF1 (Currier et al., 2018).

A Molecular Arms Race Between Humans and Trypanosomes
A molecular arms race has led to the evolution of human-infective
Trypanosoma brucei rhodesiense and gambiense parasites that overcome APOL1mediated lysis. T.b. rhodesiense is a zoonotic parasite found in Eastern and Southern
Africa that causes an acute form of sleeping sickness in humans. It is differentiated
from T. brucei by the presence of a single gene, evolved from a VSG, termed serum
resistance associated (SRA) protein. SRA localizes to the endosomes and lysosome
of the parasite and directly binds to APOL1, preventing trypanolysis (Perez-Morga
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et al., 2005). SRA binds to the C-terminus of APOL1 at acidic pH, and in planar lipid
bilayer experiments it prevents rAPOL1 channel formation. Within bilayers pretreated with rSRA at pH 5.5, addition of rAPOL1 still leads to the small, initial
current, signifying insertion. However, upon neutralization not only is there no
channel opening, but the small current depicting rAPOL1 insertion is lost (Thomson
and Finkelstein, 2015). This suggests that SRA allows for initial insertion but
prevents oligomerization, which is likely due to its binding of the leucine zipper
domain at the C-terminus (Thomson and Finkelstein, 2015; Zoll et al., 2018).
Expression of SRA in TLF-susceptible T. brucei leads to complete resistance
(Vanhamme et al., 2003).
T.b. gambiense is found in Central and Western Africa and causes the chronic
form of sleeping sickness. It accounts for over 90% of sleeping sickness cases in
humans (Simarro et al., 2010) and utilizes a multi-pronged approach to evade TLF
lysis. The T.b. gambiense HpHbR contains a single amino acid change, L210S, that
greatly reduces binding to both HpHb and HprHb. Additionally, T.b. gambiense
contains the TgsGP gene, also evolved from a VSG, that is proposed to stiffen
intracellular membranes and prevent APOL1 insertion in the endo/lysosome
(Capewell et al., 2013; Uzureau et al., 2013). The selective pressure from these
parasites is thought to be the driving force behind two alleles of APOL1, which arose
2,000-10,000 years ago in sub-Saharan Africa, that provide humans with at least
partial immunity from trypanosome infection.
The recently evolved sub-Saharan African alleles of APOL1 are G1, which
contains a two amino acid substitution (S342G and I384M), and G2, which has a six
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base pair deletion that removes N388 and Y389 (Genovese et al., 2010). For both
alleles, the mutations are at the C-terminus, either in the last predicted
transmembrane or leucine zipper domains. The leucine zipper mutations occur in
the APOL1 region that binds to SRA (Thomson et al., 2014; Vanhamme et al., 2003;
Zoll et al., 2018). Surface plasmon resonance using C-terminal peptides of APOL1
and rSRA revealed that, compared to wild-type G0, G1 and G2 had two and five-fold
reduced binding, respectively. This was corroborated by HGD in mice infected with
T. brucei overexpressing SRA (mimicking T. b rhodesiense). In this study, empty
vector and G0 offered no protection, G1 provided partial protection, and G2 offered
the most protection to the infected mice (Thomson et al., 2014). In a small
epidemiological study of T.b. rhodesiense and gambiense infected patients, however,
it was discovered that G1 offered no immunity against T.b. rhodesiense. This is not
unexpected due to G1 having only a modest reduction in SRA binding and offering
only partial protection against SRA-expressing trypanosomes. However, G1 was
associated with asymptomatic T.b. gambiense infection, which is diagnosed by
detection of trypanosomes in the bloodstream but not the cerebrospinal fluid,
indicating that the parasites could not cross the blood-brain barrier. The mechanism
underlying G1 immunity from sleeping sickness caused by T. b. gambiense remains
unknown. Surprisingly, G2 was linked to a more severe patient outcome from T.b.
gambiense infection. As expected, however, G2 was associated with immunity
against T.b. rhodesiense, consistent with the aforementioned in vivo and in vitro
experiments (Cooper et al., 2017). The immunity imbued by G1 and G2 come at a
price, however, as both alleles are strongly associated with kidney disease.
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The Casualties of War: Newly Evolved APOL1 Alleles Cause Kidney
Disease
People with two copies of G1 or G2 have a significantly increased risk of
developing a myriad of forms of non-diabetic chronic kidney disease (CKD)
(Genovese et al., 2010). The APOL1 variants are thought to be a significant factor in
explaining the high rate of CKD in African-Americans (AAs), and extrapolation of
patient data estimates that up to 5 million AAs carry the risk genotype (Friedman et
al., 2011). The risk genotypes are associated with AA lifetime risk of developing
focal segmental glomerulosclerosis (FSGS) increasing from 0.8% to 4.25%,
hypertension-associated end stage kidney disease (HA-ESKD) from 2.75 to 11%, and
HIV-associated nephropathy (HIVAN), when the infection is left untreated, from
10% to 50% (Dummer et al., 2015; Genovese et al., 2010; Kopp et al., 2011; Tzur et
al., 2010). G1 and G2 are also associated with sickle cell nephropathy, lupus
nephritis, and aterionephroslcerosis (Ashley‐Koch et al., 2011; Freedman et al.,
2014; Lipkowitz et al., 2013). Importantly, the risk genotype also causes faster
progression from CKD to ESKD (Parsa et al., 2013).
A follow-up study on kidney function was performed on the patient lacking
functional APOL1 as well as 50 fellow villagers, 8 of which contained a single null
APOL1 allele. No change in kidney health or function was reported, demonstrating
that APOL1 is not required for normal kidney function (Johnstone et al., 2012), and
also suggests that while the disease phenotype is inherited recessively, G1 and G2
represent gain of function mutations. This is supported by the fact that APOL1 is
associated with various forms of kidney disease. Additionally, the low penetrance of
9

the disease phenotype suggests that environmental triggers, such as an HIV
infection, are necessary to trigger disease (Langefeld et al., 2018; Lee et al., 2012a)
Interestingly, no difference between G1 or G2 homozygotes, or compound
heterozygotes, has been reported in terms of disease type or risk. As APOL1
continuously circulates in the bloodstream as part of TLF, the question became
whether extracellular or intracellular APOL1 leads to disease.

Intracellular APOL1 Leads to Kidney Disease
Multiple studies aimed at discovering the source of APOL1 that leads to
kidney disease suggest that intracellular APOL1 is the culprit. Two separate
retrospective transplant studies compared allograft survival in patients, with
knowledge of either donor or recipient APOL1 genotype. They discovered that
kidneys from donors with two risk alleles had a significantly lower rate of survival,
while the genotype of recipients had no effect (Lee et al., 2012a; Reeves-Daniel et al.,
2011). Another study analyzed circulating levels of APOL1 and its variants using
liquid chromatography mass spectrometry on serum samples of 3,450 individuals.
They reported no difference in APOL1 levels in patients with or without symptoms
of kidney disease (Kozlitina et al., 2016). An additional study reported that a small
set of patients developed collapsing FSGS after an intense 4-12 month course of
interferon (IFN) treatment (Markowitz et al., 2010). As IFNs stimulate expression of
APOL1, a retrospective study genotyped these patients and discovered that all of
them carried the APOL1 risk genotype (Nichols et al., 2015). Taken to together these
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studies support the hypothesis that APOL1 endogenous to the kidney is the cause of
CKD, and that upregulation of APOL1 can lead to disease.
A large portion of APOL1-associated kidney diseases affect the podocyte,
which are epithelial cells that facilitate filtration by partially forming the glomerular
basement membrane, as well as creating the final barrier of filtration by interlocking
their foot processes around the capillaries of the glomerulus. Analysis of human
tissues samples revealed expression of APOL1 mRNA in several tissues types,
including the kidney (Duchateau et al., 2001; Monajemi et al., 2002). Additionally,
immunohistochemistry of kidney biopsies revealed APOL1 protein expression
within podocytes (Ma et al., 2014; Madhavan et al., 2011). In culture, podocytes
express low levels of APOL1 mRNA that increases up to ten-fold upon stimulation
with IFN, and transient overexpression of G1 and G2 in these cells is highly cytotoxic
(Nichols et al., 2015). These data have led to the study of APOL1 and disease in cell
culture.
G1 and G2 are cytotoxic to several different cell types when overexpressed,
including podocytes (Cheng et al., 2015; Heneghan et al., 2015; Lan et al., 2014;
Olabisi et al., 2016). G0 is also cytotoxic in transient overexpression systems,
however significantly less so than G1 or G2 (Lan et al., 2014). APOL1 cytotoxicity is
characterized by cell swelling followed by lysis (Olabisi et al., 2016), a phenotype
similar to that seen in TLF or human serum treated trypanosomes (Rifkin, 1984).
The mechanism behind APOL1-mediated cell death remains highly controversial,
with many cell death pathways implicated. We aimed to elucidate the mechanism by
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which APOL1 is cytotoxic to cells, and began by evaluating the claim that APOL1 kills
by activating autophagy (Wan et al., 2008).

APOL1 and Autophagy
Autophagy is the process by which cells can recycle organelles and
cytoplasmic material, a process that is markedly increased in times of stress.
Activation of this pathway leads to formation of double-membrane vesicles termed
autophagosomes, which contain cellular material and are fused with endosomes and
lysosomes for degradation. Autophagy is not only considered a pro-survival process
in times of nutrient depletion, but also essential for maintaining cellular
homeostasis (Colombo and Simon, 2009). However, a sustained increase of
autophagic turnover is thought to a drive autophagic cell death (ACD), a unique
programmed cell death pathway in which the cell is hypothesized to cannibalize
itself (Levine and Kroemer, 2008). Autophagy is regulated by many factors,
including proteins containing a Beclin-2 homology (BH) domain (Maiuri et al.,
2007a), a domain that APOL1 is proposed to contain (Wan et al., 2008).
BH domain containing proteins regulate apoptotic cell death, and have
recently been proposed to regulate autophagy as well. Beclin-1, a BH3 domain
containing protein, is required to initiate formation of pre-autophagosomal
structures, and is negatively regulated by its interaction with Beclin-2 (Maiuri et al.,
2007b). This interaction occurs through the amphipathic helix of the BH3 domain
and can be disrupted by other BH3 containing proteins as well as BH3 mimetic
compounds, thereby initiating autophagy (Maiuri et al., 2007a). As APOL1 was
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predicted to contain a single BH3 domain, and its overexpression in mammalian
cells led to an increase in autophagy, it was proposed that APOL1 cytotoxicity
occurred via ACD (Wan et al., 2008).
Deletion of the predicted BH3 domain of APOL1 completely rescued cells
from its cytotoxicity. Treatment with chemical inhibitors of autophagy, such as
wortmannin, was also protective. This led the authors to propose that ACD was the
driver of APOL1-mediated cell death (Wan et al., 2008). However, we were skeptical
of their methods, most notably the deletion of the 9 amino acid BH3 domain, which
we hypothesized was deleterious to normal protein function. Additionally, whether
or not autophagy drives cell death as often as proposed is controversial as the mere
presence of autophagic flux during cell death does not mean that it is the cause
(Barth et al., 2010; Kroemer and Levine, 2008). This prompted us and our
collaborators to further investigate the link between APOL1 and autophagy.

The Cytotoxicity and Cell Death Mechanisms of the APOL Family
APOL family members have also been implicated with cytotoxicity and
programmed cell death pathways. APOL2 and 6 are predicted to contain a single
BH3 domain, similar to that of APOL1 (Liao et al., 2011; Liu et al., 2005).
Overexpression of APOL6 in DLD1 cells is cytotoxic and leads to cleavage of caspases
8 and 9 and release of cytochrome c into the cytosol, implicating apoptotic cell death
(Liu et al., 2005). Contrarily, APOL2 was proposed to prevent apoptotic cell death in
human bronchial epithelial cells that were stimulated with IFNγ (Liao et al., 2011).
However, further work performed in HeLa cells indicated no role for APOL2 in IFN-
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related cell death or apoptosis (Galindo-Moreno et al., 2014). While the
phenomenon may therefore be cell-type specific, the role of APOL2 in apoptosis
remains unclear. Finally, purified rAPOL3 kills T. brucei, though the toxicity does not
seem specific to trypanosomes, as rAPOL3 was also lethal to mice when injected
(Fontaine et al., 2017). These data indicate the APOL gene family is directly involved
in promoting or inhibiting cytotoxicity through various mechanisms. We aimed to
further investigate the cytotoxicity of the APOL family members, as well as their
channel-forming properties and associated cell death pathways.

Cytotoxicity of APOL1 Is Linked with Multiple Cell Death Pathways
The cytotoxicity of APOL1 has been associated with multiple cell death
pathways. Transient transduction of G1 and G2, and to a lesser extent G0, led to
lysosomal rupture in podocytes. This was evidenced by release of cathepsin-L into
the cytosol 48h after transduction (Lan et al., 2014). In another study,
overexpression of G1 and G2 in stably transfected HEK293 cells led to upregulation
of genes involved in mitochondrial function, among others. Mitochondrial
respiration rates were decreased by G1 and G2 overexpression, leading the authors
to suggest mitochondrial dysfunction as the driver of APOL1-mediated cell death
(Ma et al., 2017). Other studies have also suggested apoptosis in rat liver cells
(Cheng et al., 2015), binding to and activation of αvβ3 integrin receptors in
podocytes (Hayek et al., 2017), or the impairment of vacuole acidification in yeast as
the causes of APOL1 cytotoxicity (Kruzel-Davila et al., 2017).
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Pyroptosis, the programmed necrotic cell death pathway that utilizes
inflammation-regulated caspases to trigger toxic pore formation by Gasdermin-D
(Liu et al., 2016), was also implicated in APOL1-mediated cell death. Overexpression
of G1 and G2 in HeLa cells led to the cleavage of caspase-1 and release of cytosolic
interleukin-1β, hallmarks for pyroptosis. Treatment of HEK293 cells with the
caspase-1 specific inhibitor Ac-YVAD-CHO rescued G1 and G2 cytotoxicity
(Beckerman et al., 2017). However, it should be noted that HEK293 cells lack the
necessary machinery to undergo pyroptosis (Bast et al., 2014), so it is surprising
that a chemical inhibitor of pyroptosis is protective . Finally, the same study
generated a transgenic mouse that utilized doxycycline controlled expression of
APOL1 behind a podocyte-specific promoter, G1 and G2 overexpression led to
increased staining of pyroptosis-related proteins, most notably caspase-1, in the
glomerulus. Taken together, the authors suggest that overexpression of G1 and G2
activates pyroptosis, which triggers podocyte cell death (Beckerman et al., 2017).
The p38 MAPK pathway is protective against pore-forming toxins (PFTs)
(Cancino-Rodezno et al., 2010; Porta et al., 2011) and is associated with APOL1
overexpression. In C. elegans, treatment with a sub-lytic dose of the PFT Cry5B was
toxic when p38 MAPK was knocked down. Additionally, baby hamster kidney cells
were more susceptible to the PFT aerolysin when p38 MAPK was chemically
inhibited with SB203580 (Huffman et al., 2004). Overexpression G1 and G2 in
TREX293 cells, a stably transfected HEK293 cell line, also activated p38 MAPK
(Olabisi et al., 2016). Activation of this pathway was linked to APOL1-mediated K+
efflux from the cell, a phenotype that has been observed in mammalian cells treated
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with various PFTs (Kloft et al., 2009). Culturing TREX293 in media that replaced Na+
with K+ inhibited both cytotoxicity and p38 MAPK activation. Surprisingly, inhibition
of p38 MAPK with SB203580 exacerbated, rather than rescued, the cytotoxicity of
G1 and G2 (Olabisi et al., 2016).
This lack of consensus is biologically unsatisfying and motivated us to search
for a common trigger for these phenomena. Evidence suggests that APOL1 leads to
channel formation when overexpressed in animal cells (Heneghan et al., 2015;
O'Toole et al., 2018; Olabisi et al., 2016), mirroring its activity in trypanosomes. As
PFTs lead to similar cellular phenotypes and cell death pathways as G1 and G2
overexpression (Cancino-Rodezno et al., 2010; Porta et al., 2011), we hypothesized
that the kidney disease variants of APOL1 act in the same vein by forming cationselective channels at the PM.

APOL1 Channel Formation at the PM
The major spliced isoform of APOL1 encodes a signal peptide for trafficking
along the secretory pathway (Monajemi et al., 2002; Nichols et al., 2015). The
secretory pathway is initiated by translation of the protein in the endoplasmic
reticulum (ER), followed by trafficking along the Golgi. APOL1 does not contain
additional trafficking signals and likely traffics through secretory vesicles or
recycling endosomes to reach the PM. Along this route, the pH of the trans-Golgi and
secretory vesicles is approximately 6.0 and 5.7, respectively (Paroutis et al., 2004), a
pH range that was sufficient for rAPOL1 insertion into planar lipid bilayers
(Thomson and Finkelstein, 2015). If APOL1 is able to insert in this acidic
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environment then the channel will assemble (oligomerize), and upon delivery to the
neutral environment of the PM, the channel will open and allow for an ion flux
across the PM.
Localization studies support the hypothesis of APOL1 channel formation at
the PM. Within IFNγ-stimulated podocytes, 90%-95% of endogenous APOL1 is
localized to the endoplasmic reticulum (ER), with the remaining APOL1 found at the
PM (Scales et al., 2017). PM localization is also reported when APOL1 is
overexpressed in TREX293 cells and cRNA injected Xenopus oocytes (Heneghan et
al., 2015; O'Toole et al., 2018). In agreement with podocyte study, the majority of
overexpressed APOL1 in hepatocytes resides in the ER. Importantly, little to no
secretion of APOL1 is detected in cell culture (Cheng et al., 2015), and within the
human body approximately 90% of circulating APOL1 is synthesized in the liver
(Shukha et al., 2016). These data indicate that, while APOL1 traffics along the
secretory pathway, it may have a function at the PM in certain cell types. Indeed,
immunohistochemistry of human kidney biopsies revealed robust expression of
APOL1 protein within the glomerulus in cells expressing the podocyte markers WT1
and GLEPP1 (Ma et al., 2014; Madhavan et al., 2011). Additionally, podocytes in
culture expressed APOL1 mRNA and protein (Nichols et al., 2015; Scales et al.,
2017). It is possible that some APOL1 protein detected in podocytes is from the
splice isoforms lacking a signal peptide. However, at basal levels only mRNA from
the spliced isoform containing the signal peptide is detected in culture, and upon
IFN stimulation, this isoform is expressed several times higher than the intracellular
isoforms (Nichols et al., 2015). These data demonstrate that APOL1 is present in
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podocytes and localizes to the ER and PM, where it may form cation-selective
channels in the PM.
Overexpression of APOL1 elicits a current across the PM. This was detected
in patch-clamped TREX293 cells and Xenopus oocytes (Heneghan et al., 2015;
O'Toole et al., 2018). Lowering the pH below 6.0 inhibited the current, consistent
with the properties of pH gating observed with rAPOL1 in planar lipid bilayers
(Thomson and Finkelstein, 2015). APOL1 also led to Na+ influx, K+ efflux, and cell
swelling (O'Toole et al., 2018; Olabisi et al., 2016), events that occur in TLF or
human serum treated trypanosomes (Rifkin, 1984) and that suggest formation of
cation-selective channels. Interestingly, in oocytes APOL1 also led to the
intracellular accumulation of 45Ca2+ from the extracellular environment (Heneghan
et al., 2015). As Ca2+ is a potent signaling molecule, we were interested in studying
what effects Ca2+ had on the cytotoxicity of APOL1.

Ca2+ Signaling
Ca2+ regulates many signaling pathways and cellular processes. In order to
facilitate rapid signaling, free Ca2+ in the cytosol is maintained at 100-200nM, while
extracellular Ca2+ typically ranges from 1-3mM. In order to maintain this basal level
of Ca2+, the plasma membrane Ca2+ ATPase (PMCA) pump as well as Na+/Ca2+ and
Na+/Ca2+-K+ exchangers transport Ca2+ across the PM (Clapham, 2007). Increases in
cytosolic Ca2+ typically occur from two places: Extracellularly through the action of
voltage or ligand gated Ca2+ channels at the PM, or by release from the ER via
activation of the Ryanodine or IP3-binding Ca2+ release receptors on the ER
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membrane (Prakriya and Lewis, 2015). The ubiquity of various Ca2+ binding and
adapter proteins throughout the cell allows for small increases in cytosolic Ca2+ to
have large, localized effects.
The ER acts as a Ca2+ store and typically contains 100-800µM Ca2+, and ER
Ca2+ release is integral to initiate many intracellular inflammatory and signaling
pathways. Once Ca2+ is released from the ER, the stores are replenished via the
action of store-operated Ca2+ channels (SOC). This utilizes the luminal Ca2+ sensor
STIM1, which then binds to the SOCs Ora1 and 2 at ER:PM junctions, facilitating a
cytosolic Ca2+ influx. The Ca2+ is then pumped back into the ER via the
sacroendoplasmic reticular Ca2+ ATPase (SERCA). In addition to the ER,
mitochondria also play a role in Ca2+ signaling and can buffer cytosolic Ca2+(Prakriya
and Lewis, 2015). As APOL1 leads to uptake of Ca2+ (Heneghan et al., 2015), it may
affect these signaling processes.
Accumulation of intracellular Ca2+ by APOL1 can have large effects on the
cell, and may play an important role in the cell death mechanisms that APOL1 has
been associated with. Indeed, increased intracellular Ca2+ can activate the NLRP3
inflammasome complex that initiates pyroptosis (Lee et al., 2012b). Additionally, the
mitochondria can act as a Ca2+ sink for increasing cytosolic Ca2+ levels. If Ca2+ levels
persist, the mitochondria may become overloaded, leading to collapse of the
electrochemical proton gradient, mitochondrial swelling, and necrotic cell death
(Rizzuto et al., 2012). Ca2+ also plays an important role in apoptosis (Pinton et al.,
2008).

19

Due to the many roles Ca2+ has within the cell, we were motivated to study
whether or not APOL1 leads to a Ca2+ influx in mammalian cells and what effects, if
any, Ca2+ levels have on APOL1 cytotoxicity. Additionally, we set out to elucidate the
source of Ca2+, and whether or not APOL1 itself forms channels that are permeable
to Ca2+. Finally, if APOL1 indeed forms Ca2+-selective channels at the PM, we
hypothesize that it leads to the activation of the Ca2+-regulated wound healing
pathways.

Ca2+ Activated Wound Healing Pathways Protect Cells From PFTs
There are two independent Ca2+ activated wound healing pathways within a
cell that repair the PM; Lysosomal exocytosis followed by endocytosis of the lesion,
and endosome sorting complexes required for transport (ESCRT)-III-mediated
membrane shedding. Both of these pathways remove the lesion from the PM, which
is required for survival against PFTs. The influx of Ca2+ is essential, as removal or
chelation of extracellular Ca2+ greatly sensitizes mammalian cells to a wide range of
PM injuries, from the PFT streptolysin O (SLO) to UV-laser (Idone et al., 2008;
Jimenez et al., 2014).
The lysosomal wound healing pathway is initiated by an influx of Ca2+ that is
detected by the lysosome bound synaptotagmin VII (SytVII). Once bound to Ca2+,
SytVII facilitates the fusion of peripheral lysosomes with the PM (Idone et al., 2008;
Reddy et al., 2001). Release of the lysosomal enzyme acid sphingomyelinase near
the wound site remodels the affected membrane by converting sphingomyelin on
the outer leaflet of the PM to ceramide, which drives tighter membrane packing and
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invagination. Invaginated membrane is then endocytosed via caveolins and the
affected membrane, along with any PFTs, is degraded (Figure 1A) (Tam et al., 2010).
ESCRT-III buds membrane away from the cytoplasm, either into organelles
or the extracellular environment (Alonso et al., 2016). In the case of wound healing,
the ESCRT-III components are recruited to the site of Ca2+ influx by apoptosis-linked
gene (ALG)-2, which contains Ca2+ binding domains, and ALG-2 interacting protein X
(ALIX). Once at the site, the ESCRT-III components interact and polymerize to drive
membrane remodeling and budding (Jimenez et al., 2014; Scheffer et al., 2014). In
order for the complex to disassemble, and also possibly for the final step of
membrane scission, the type-I ATPase vacuolar protein sorting (Vps) 4 is required
(Figure 1B) (Alonso et al., 2016). Overexpression of a dominant-negative form of
Vps4b, which is incapable of ATP hydrolysis (Fujita et al., 2003), prevents ESCRT-IIImediated budding and sensitizes cells to UV-laser wounding(Jimenez et al., 2014).
Interestingly, APOL1 was detected in ALIX-containing microvesicles when
overexpressed in HEK293 cells (Taylor et al., 2014), suggesting that APOL1 activates
the ESCRT-III wound healing pathway.
We hypothesize that if APOL1 directly leads to an influx of Ca2+ across the
PM, then these wound healing pathways will be activated to promote cell survival
against the threat of APOL1 channel formation.
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Research Questions
Chapter 1
•

Is the BH3 domain of APOL1 required for cytotoxicity

•

Is deletion of the 9 amino acid BH3 domain deleterious to APOL1 function

•

Is autophagy the driver of APOL1-mediated cell death

•

What other members of the APOL gene family encode cytotoxic proteins, and
via what mechanism are they cytotoxic

Chapter 2
•

Does APOL1 form channels that are permeable to Ca2+

•

What effects, if any, do extracellular Ca2+ levels have on APOL1 cytotoxicity

•

Does APOL1 lead to an influx of Ca2+

•

If APOL1 does form channels, are they localized to the PM

•

Why is G0 minimally toxic compared to G1 or G2

Chapter 3
•

Does APOL1 activate the lysosomal or ESCRT-III wound healing pathways
when overexpressed

•

Does modulation of the wound healing pathways affect cell survival against
the cytotoxicity of APOL1
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Materials and Methods
Cloning and vector construction
APOL1-G0 (BC143038.1) cDNA in the PRG977 plasmid (ubiquitin promoter)
was first mutated to substitute the lysine at residue 150 to glutamic acid (K150)
using the QuikChange II Mutagenesis Kit (Agilent 200523). To generate G1, two
rounds of mutagenesis were performed (S342G, I384M), and to generate G2, N388
and Y389 were deleted. cDNA for G0, G1, and G2 were inserted into the
pcDNA5/FRT/TO (Thermo V652020) mammalian expression vector between the
EcoRV and XhoI cut sites. APOL1 cDNA was also inserted into the Str-KDEL_SBPEGFP-GPI (RUSH) vector (Addgene 65293) between the SbfI and XbaI cut sites,
removing EGFP-GPI. The APOL1 cDNA inserted into the RUSH contained the
sequence just downstream of the signal peptide cleavage site at A27. All BH3
mutations and deletions, KDEL and KKXX signal sequence additions, and signal
peptide deletion were performed on APOL1-G0 in PRG977.
We received plasmids from the Harvard PlasmID Database containing APOL2
(Accession number: DQ893431.2, Harvard plasmid ID number: HsCD00045448),
APOL3 (NP_055164.1, HsCD00431226), APOL4 (NM_145660.2, HsCD00431838),
APOL5 (NM_030642.1, HsCD00431854), and APOL6 (NM_030641.3,
HsCD00073674). APOL2-6 cDNA were cloned into PRG977 between the XbaI and
EcoRI I cut sites. The putative signal peptide of APOL4 was removed by PCR of the
original cDNA with a new forward primer. In order to tag N-terminally tag APOL1-6,
G-blocks (custom designed double stranded DNA) were ordered from IDT
containing either a Myc-tag or 3xFLAG tag with a 2xGGSGG linker and inserted into
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PRG977 between the XbaI and XhoI cut sites, placing them upstream of the APOL
cDNA. For APOL1, G-blocks were ordered with the APOL1 signal peptide sequence
followed by the tag, and the rest of the APOL1 cDNA was inserted just downstream
of the tag. Once the 4 new tagged PRG977 vectors were generated (Myc, 3xFLAG,
APOL1 signal peptide Myc, APOL1 signal peptide 3xFLAG), cDNA of the APOLs was
inserted between the XbaI and EcoRI cut sites. Each APOL cDNA was tagged with
Myc and 3xFLAG.
The multi-cloning site of PRG977 was converted to contain unique cut sites
NdeI, PciI, NheI, and NsiI. This was performed with 5’ phosphorylated primers that
contained the new MCS sequences split between two primers. The primers annealed
to PRG977 on either side of the original multi-cloning site. Around the world PCR
was performed followed by ligation. Next, the ubiquitin promoter was replaced with
a CMV promoter from the pCMVTnT vector (Promega). The ubiquitin promoter from
PRG977 was cut out using the KpnI and SalI restriction enzymes, and CMV was
inserted in its place. Human Vp4sb cDNA was ordered from the DNASU Plasmid
Repository (DNASU number: HsCD00295797) and cloned into PRG2 between the
PciI and NsiI cut sites. The E235Q mutation for Vps4bDN was generated via
mutagenesis.
Primer list
Forward primers listed first
APOL1-G0 K150E Mutagenesis
5’ TGAAAGAGTTTCCTCGGTTGAAAAGTGAGCTTGAGGATAAC 3’
5’ GTTATCCTCAAGCTCACTTTTCAACCGAGGAAACTCTTTCA 3’
APOL1-G0 E150 Conversion to G1 Mutagenesis (2 rounds)
Round 1 S342G
5’ CGGATGTGGCCCCTGTAGGCTTCTTTCTTGTG 3’
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5’ CACAAGAAAGAAGCCTACAGGGGCCACATCCG 3’
Round 2 I384M
5’ GGAGCTGGAGGAGAAGCTAAACATGCTCAACAATAATTATAAGA 3’
5’ TCTTATAATTATTGTTGAGCATGTTTAGCTTCTCCTCCAGCTCC 3’
APOL1-G0 E150 Conversion to G2 Mutagenesis
5’ AGCTAAACATTCTCAACAATAAGATTCTGCAGGCGGAC 3’
5’ GTCCGCCTGCAGAATCTTATTGTTGAGAATGTTTAGCT 3’
APOL1 into pcDNA5
5’ ATGATATCGCCACCATGGAGGGAGCTG 3’
5’ ATCTCGAGTCATCACAGTTCTTGGTCCGCCTG 3’
APOL1 into Str-KDEL_SBP-EGFP-GPI (RUSH)
5’ ATGCCCTGCAGGAGAGGAAGCTGGAGCGAGG 3’
5’ ATGCTCTAGACTATCACAGTTCTTGGTCCGCC 3
APOL1 BH3 deletion
5’ GAGGATAACATAAGAAGGAAGGTCCACAAAGGCACC 3’
5’ GGTGCCTTTGTGGACCTTCCTTCTTATGTTATCCTC 3’
APOL1 L158A
5’ GAGGATAACATAAGAAGGGCCCGTGCCCTTGCAGATC 3’
5’ GATCTGCAAGGGCACGGGCCCTTCTTATGTTATCCTC 3’
APOL1 R158A
5’ ATAACATAAGAAGGCTCGCTGCCCTTGCAGATGGGG 3’
5’ CCCCATCTGCAAGGGCAGCGAGCCTTCTTATGTTAT 3’
APOL1 D163A
5’ CCGTGCCCTTGCAGCTGGGGTTCAGAAGG 3’
5’ CCTTCTGAACCCCAGCTGCAAGGGCACGG 3’
APOL1 triple mutant. Add L158A and R158A to D163A
5’ TGAGGATAACATAAGAAGGGCCGCTGCCCTTGCAGCTGGGG 3’
5’ CCCCAGCTGCAAGGGCAGCGGCCCTTCTTATGTTATCCTCA 3’
APOL1 KDEL addition
5’ CAGGCGGACCAAGAACTGAAAGATGAACTGTGAGAATTCGAGATCTAG 3’
5’ CTAGATCTCGAATTCTCACAGTTCATCTTTCAGTTCTTGGTCCGCCTG 3’
APOL1 KKEL mutagenesis from KDEL
5’ GCAGGCGGACCAAGAACTGAAAAAAGAACTGTGAGAATTC 3’
5’ GAATTCTCACAGTTCTTTTTTCAGTTCTTGGTCCGCCTGC 3’
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APOL2 into PRG977
5’ ATTCTAGAGCCACCATGAACCCAGAGAGCAGTATC 3’
5’ ACTGGAATTCTCACTATTGGTCTTGGCCTGGCTGCAG 3’
APOL3 into PRG977
5’ AATCTAGAGCCACCATGGACTCAGAAAAGAAACGCTTTAC 3’
5’ GATCGAATTCTCATCAGTGGGTATGGCATGGATTCAGAC 3’
APOL4 into PRG977
5’ AATCTAGAGCCACCATGGAGGGAGCTGC 3’
5’ GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG 3’
APOL5 into PRG977
5’ AATCTAGAGCCACCATGCCATGTGGCAAAC 3’
5’ GATCGAATTCTCATTATTGTCGGTGTCTTCCCGGG 3’
APOL6 into PRG977
5’ AATCTAGAGCCACCATGGACAACCAGGC 3’
5’ GATCGAATTCTCATCATGTAAACTGTACATACACACAGAC 3’
APOL1-G0 conversion to isoform 3, signal peptide deletion (Uniprot O14791)
5’ CTGTCCTCTGCATCTGGGTGCAACAAAACGTTCC 3’
5’ GGAACGTTTTGTTGCACCCAGATGCAGAGGACAG 3’
APOL4 conversion to isoform 2, signal peptide deletion (Uniprot Q9BPW4-2)
5’ GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG 3’
5’ GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG 3’
G-block for myc tag at N-terminus of PRG977
5’GTCTCATCATTTTGGCAAAGAATTTATGCCTCGAGGCTAGCGCCACCATGGAACAAAA
ACTCATCTCAGAAGAGGATCTGGGTGGCAGCGGAGGTGGAGGCTCAGGTGGCTCTAGAA
TGCTTTGGGAACCCGGGTCTCT 3’
G-block for 3xFLAG tag at N-terminus of PRG977
5’TATGCCTCGAGGCTAGCGCCACCATGGACTACAAAGACCATGACGGTGATTATAAAGA
TCATGATATCGATTACAAGGATGACGATGACAAGGGTGGCAGCGGAGGTGGAGGCTCAG
GTGGCTCTAGAATGCT 3’
G-block for APOL1-SP followed by myc-tag at N-terminus of PRG977 (uppercase
denotes APOL1 sequence)
5’ tatgcctcgaggctagcgccaccatgGAGGGAGCTGCTTTGCTGAGAGTCTCTGTCCTCTGCAT
CTGGATGAGTGCACTTTTCCTTGGTGTGGGAGTGAGGGCAatgcatgaacaaaaactcatctcaga
agaggatctgggtggcagcggaggtggaggctcaggtggctctagaatgct 3’
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G-block for APOL1-SP followed by 3xFLAG-tag at N-terminus of PRG977 (uppercase
denotes APOL1 sequence)
5’ tatgcctcgaggctagcgccaccatgGAGGGAGCTGCTTTGCTGAGAGTCTCTGTCCTCTGCAT
CTGGATGAGTGCACTTTTCCTTGGTGTGGGAGTGAGGGCAatgcatgactacaaagaccatgacgg
tgattataaagatcatgatatcgattacaaggatgacgatgacaagggtggcagcggaggtggaggctcaggtggctct
agaatgct 3’
APOL1 (downstream of signal peptide cleavage site) insertion into tagged PRG977
5’ ATGCTCTAGAGAGGAAGCTGGAGCGAGG
5’ TCAACGAATTCTCACAGTTCTTGGTCCGCC 3’
APOL1 isoform 3 insertion into tagged PRG977
5’ATGCTCTAGAGAGGGAGCTGCTTTGCTGAG
5’ TCAACGAATTCTCACAGTTCTTGGTCCGCC 3’
APOL2 insertion into tagged PRG977
5’ ATGCTCTAGAAACCCAGAGAGCAGTATCTTTATTG 3’
5’ ACTGGAATTCTCACTATTGGTCTTGGCCTGGCTGCAG 3’
APOL3 insertion into tagged PRG977
5’ ATGCTCTAGAGACTCAGAAAAGAAACGCTTTACTG 3’
5’ GATCGAATTCTCATCAGTGGGTATGGCATGGATTCAGAC 3’
APOL4 with signal peptide insertion into tagged PRG977
5’ ATGCTCTAGAGAGGGAGCTGCTTTGCTGAAAATC 3’
5’ GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG 3’
APOL4 without signal peptide insertion into tagged PRG977
5’ATGCTCTAGAGGATCCTGGGTGCAGCTCATC 3’
5’ GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG 3’
APOL5 insertion into tagged PRG977
5’ATGCTCTAGACCATGTGGCAAACAAGGAAATTTGC 3’
5’ GATCGAATTCTCATTATTGTCGGTGTCTTCCCGGG 3’
APOL6 insertion into tagged PRG977
5’ATGCTCTAGAGACAACCAGGCGGAGAGAGAAAG 3’
5’ GATCGAATTCTCATCATGTAAACTGTACATACACACAGAC 3’
PRG977 conversion to PRG2 with new multi-cloning site
5’ Phos – GGATGCATCCTAGTAACATGTTAATCAGCCATACCAC 3’
5’ Phos – CTGCTAGCCATGGACATATGAATTCTTTGCCAAAATGA 3’
CMV promoter into PRG2
5’ ATGGTACCATCGATATAGTAATCAATTACGGGGTCATTAG 3’
5’ ACTGTCGACGATATCAGCTCTGCTTATATAGACCTCC 3’
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Vps4b into PRG2-CMV
5’ ATGCACATGTGCCACCATGTCATCCACTTCGCCCAAC 3’
5’ ATGCATGCATCTATCAGCCTTCTTGACCAAAATCTTCTG 3’
Vps4bDN E235Q mutagenesis
5’ CCCTCCATTATCTTCATTGATCAAATTGATTCTCTCTGTGGTT 3’
5’ AACCACAGAGAGAATCAATTTGATCAATGAAGATAATGGAGGG 3’

Generation and maintenance of FlpIn TREX293 cells
FlpIn 293 cells from Thermo Scientific were maintained in DMEM (Corning
10-017-CM) with Zeocin (Gibco R25001) at 100µg/mL. To establish a FlpIn
TREX293 (FT293) line, cells were transfected with pcDNA6/Tet-Repressor
linearized with PciI. The media was replaced the day after transfection, and the next
day cells were trypsinized and seeded at approximately 20% confluency. 4h after
seeding, the media was replaced to that containing Zeocin at 100µg/mL and
blasticidin (Gibco R21001) at 5µg/mL. Media was changed every 3-4 days for 2-3
weeks until foci formed. Several foci were picked, expanded, and assayed for
repressor activity and expression using a transient transfection of APOL1
pcDNA5/FRT/TO. A single clone was selected and expanded, and all FT293-APOL1
cells were derived from this same clone.
To generate single copy APOL1 cDNA cell lines, the Flp recombinase
containing vector pOG44 (Thermo V600520) and APOL1 pcDNA5/FRT/TO were cotransfected at a 9:1 ratio. Cells were treated as before, except 2 days after
transfection they were seeded directly into media containing blasticidin at 5µg/mL
and the new antibiotic Hygromycin B (Thermo 10687010) at 150µg/mL. 2-3 weeks
after transfection, foci were pooled and polyclonal cell lines for APOL1 G0, G1, and
G2 were expanded. Cells were then maintained in DMEM + 10% tet-free FBS,
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100µg/mL Hygromycin B, 5µg/mL blasticidin, and 1mM sodium pyruvate (Sigma
P5280). All experiments were performed in the absence of antibiotics. APOL1 cDNA
expression was induced in these cell lines with the addition of doxycycline (Sigma
D9891) to the media at various concentrations.

Cell culture and transfections
HEK293 cells were cultured in DMEM + 10% FBS, CHO cells in F12K + 10%
FBS, and conditionally immortalized podocytes (Saleem et al., 2002) in RPMI1640 +
10% FBS and ITS (Gibco 41400045). Podocytes were maintained at 33C on Type-I
collagen-coated plates. For experiments, podocytes were moved to 37C for 5-7 days
to allow for differentiation, and then treated for 24h with the indicated amounts of
Interferon-γ (R&D Systems 285IF100).
Cells were transfected with Lipofectamine 3000 prepared in Opti-MEM as
per the manufacturer’s instructions. Plasmids of different sizes were normalized by
adding the same pmol amount of DNA per tube for co-transfections. FT293 and
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HEK293 cells were transfected with 0.15uL LF3000/well in a 96 well, while CHO
cells were transfected with 0.3uL LF3000/well.
To measure the effect of extracellular Ca2+ on APOL1 cytotoxicity,
experiments with FlpIn TREX293 cells were performed in CaCl2 free DMEM (Gibco
21068-028) supplemented with 10% FBS, 4mM L-glutamine, and 1mM sodium
pyruvate, and then with or without the addition of various amounts of CaCl2 and
doxycycline. To chelate extracellular Ca2+, cells were treated with EGTA (Sigma
E3889).
Acidification of cells was performed in HEK293 cells transfected with RUSHAPOL1 plasmids. 1d after transfection, cells were treated with or without 80µM
biotin for 4h to allow for APOL1 trafficking to the PM. Media was then switched to
fresh DMEM pH 7.4 or DMEM pH 5.5, with pH lowered by addition of succinic acid.
After 1h of this treatment, media was replaced with fresh DMEM pH 7.2 with or
without 80µM biotin. 24h after acid treatment cytotoxicity was measured.
Cytotoxicity was measured via release of lactate dehydrogenase (LDH) using
the Cytotox 96 Non-Radioactive Cytotoxicity Assay (Promega G1781), and cell
viability was measured using the CellTiter 96 Cell Proliferation Assay (MTS assay)
(Promega G3580). LDH is a cytosolic enzyme that is only released from cells upon
large-scale plasma membrane damage or cell death. The LDH assay is performed on
cell culture media from treated cells, where media from each well is collected and
assayed for enzymatic activity for 30min at RT. Percent LDH release is directly
correlated to percent cell death by using 0 and 100% cell death controls (100% cell
death is generated by treatment with 0.9% Triton-X for 30min). MTS is a cell-
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permeant viability dye that is reduced by metabolically active cells. Measurement of
MTS is performed by replacement of cell culture media with 5 parts fresh media and
1 part MTS reagent, followed by incubation for 1-4h at 37C and then measurement
in a new assay plate. Percent viability is calculated by using untreated cells as 100%
alive combined with a media only control for background subtraction. Both assays
have a colorimetric readout that is measured by absorbance at 490nm.

Lysate collection and immunoblotting
To collect lysates, cells were washed in ice-cold PBS and lysed in NP-40 lysis
buffer (150mM NaCl, 1.0% NP-40, 1mM EDTA, 50mM Tris, pH 8.0 ) with HALT
protease inhibitor (Thermo 78430). Cells were incubated on a nutator for 20min at
4C, then spun down at >14,000xg for 15min at 4C. The supernatant was collected
and total protein content was quantified with the DC protein assay (Biorad
5000112). Lysates were diluted into 4xSDS Laemmli Buffer with 2.5% βmercaptoethanol, and equal amounts of protein were loaded into 10% Tris-Glycine
SDS PAGE gels (Thermo XP00100). Gels were transferred onto PVDF membrane
overnight at 4C. Membranes were blocked for 1h at RT with LICOR Odyssey PBS
Blocking Buffer (927-40000), then incubated with primary antibodies in LICOR
buffer + 0.2% Tween at room temperature for 1h or overnight at 4C. The primary
antibodies used were mouse anti-APOL1 1:2,000 (Proteintech 66124-1-Ig), rabbit
anti-APOL1 1:5,000 (Proteintech 11486-2-AP), rabbit anti-GAPDH 1:5,000
(Proteintech 10494-1-AP), and rabbit anti-β-tubulin 1:1,000 (Proteintech 10094-1AP). Blots were washed in TBS/T. Secondary antibodies were incubated in the
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LICOR buffer with the addition of 0.2% Tween and 0.01% SDS. Secondary antibodies
used were goat anti-mouse 680RD 1:10,000 (LICOR 92568070), and donkey antirabbit 800CW 1:10,000 (LICOR 925-32213). After washing with TBS/T, two final
washes were performed with plain TBS, and then blots were scanned on a LICOR
Odyssey.

Wound healing assays
The following protocol for the β-hexosaminidase assay was adapted from
(Rodríguez et al., 1997). β-hexosaminidase is a lysosomal enzyme that is only
detected in cell culture media after cell death or lysosomal exocytosis. It is therefore
a marker for lysosomal exocytosis as well as wound repair. Cells were grown to 8090% confluency and media was changed to plain DMEM with 4mM CaCl2 (serum has
a high amount of β-hexosaminidase activity). Cells were then treated with DMSO or
10-40µM Ca2+ ionophore A23187 (Sigma C7522) for 5min at 37C. After treatment,
media was immediately collected and stored on ice while the cells were washed
once quickly with ice cold PBS and then collected in NP-40 lysis buffer with HALT
protease inhibitor and moved to ice. Media was spun down for 5min >11,000 x g at
4C and supernatants were transferred to a new tube. Lysates were incubated on a
nutator for a minimum of 15min at 4C and then spun down >14,000 x g for 15min at
4C and supernatants were transferred to a new tube. Before the assay, a 6mM stock
solution of substrate was made in 1:1 acetone:water (4-Methylumbelliferyl-Nacetyl-ß-D-glucosaminide Bioworld 21530015-1). To analyze the media from each
well, 175uL of media was combined with 175µL sodium-citrate buffer (0.1M dibasic
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sodium phosphate and 0.05M sodium citrate, pH 4.5) and 50µL of substrate. Lysates
were diluted 1:5 in water and assayed in the same manner. Media and lysate
solutions were incubated at 37C for a minimum of 15min and then 100µL stop
solution was added (2M sodium carbonate, 1.1M glycine, pH 10). Samples were
transferred to a 96 well plate and analyzed via fluorescent plate reader with 365nm
excitation / 450nm emission. Percent release for each well was then calculated. In
parallel, an LDH assay was performed on the media. For longer experiments, 10%
serum in the media is best avoided, and 0.5-1% BSA can be used as a substitute.
To test the effects of ESCRT-III wound repair on APOL1 cytotoxicity, HEK293
cells were co-transfected with RUSH-APOL1 and Vps4b, Vps4bDN, or empty PRG2CMV. 24h after transfection, cells were treated with or without 80µM biotin. 48h
after transfection, cytotoxicity and cell viability were measured.

Cell surface protein biotinylation and pull-down
The following protocol was adapted from (Sharma et al., 2012). HEK293 cells
were cultured in 6cm dishes and transfected with APOL1 PRG977 vectors for 16h
before biotinylation of cell surface proteins. After 16h, cells were washed 3 times
with ice cold HBSS and then HBSS containing 0.5mg/mL EZ-link sulfo-NHS-LC-biotin
(Thermo 21335) was added for 30min at 4C. The solution was then removed, and
cells were washed once with ice cold HBSS and then quenched with 0.1M Tris-HCl
pH7.4 for 15min at 4C. Cells were then lysed in ice cold RIPA buffer (150mM sodium
chloride, 1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50mM
Tris, pH 8.0) with HALT protease inhibitor. Lysates were collected by scraping and
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incubated on a nutator for 1h at 4C. Lysates were then spun down >13,000 x g at 4C
and supernatants were collected followed by quantification of total protein content.
800µg total protein was added to 800uL streptavidin agarose resin + storage buffer
(Thermo 20349) in a spin column (Thermo 89896). The resin was first equilibrated
with 5 column volumes of 1:1 RIPA:PBS. Lysates were incubated with the resin on a
nutator at 4C for 1h then spun down, and flow through was collected. Columns were
then washed 1 time with RIPA buffer, 2 times with high salt buffer (50mM Tris-Cl
pH 8.0, 150mM NaCl), 3 times with high pH buffer (100mM sodium carbonate, pH
10.5), and two times with deionized water. Each wash contained a minimum of 3
column volumes and was spun down at 1,000 x g for 2min. High salt and high pH
washes were performed for a minimum of 5 or 10min each, respectively. Resin was
then resuspended in 200uL 2x Laemmli running buffer with 2.5% βmercaptoethanol and heated to 95C for 15min. The column was spun down and the
running buffer was collected and then run on a protein gel along with the flow
through for immunoblotting.
Future experiments should be performed with the following modifications.
Total protein input should be increased to at least 2mg for the indicated amount of
streptavidin resin. Cell surface proteins should be biotinylated with EZ-Link SulfoNHS-SS-Biotin (Thermo 21331), which is thiol-cleavable, allowing for milder
elution. Finally, heating at 95C will cause plasma membrane proteins to degrade or
crash out of solution, including the Na+/K+ ATPase, which we attempted to probe
for. Instead, elutions should be performed at 50C for 30min in 2x Laemmli buffer
with β-mercaptoethanol or dithiothreitol.
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Electrophysiology
rAPOL1 was purified from E. coli and analyzed in planar lipid bilayers as
previously described (Thomson and Finkelstein, 2015). To test for Ca2+ selectivity,
bilayers were formed with 100mM CaCl2, 0.5mM EDTA, 5mM K-HEPES, pH 7.1 on
either side. The cis pH was then adjusted to 5.6 with succinate and rAPOL1-G0 was
added. After rAPOL1 insertion, the cis side was neutralized with 1M HEPES, pH 7.5.
To test for Ca2+ permeability of rAPOL1, a 1.95 cis:trans gradient of CaCl2 was
generated by adding a 2mM CaCl2 solution to the cis side. To determine selectivity,
the voltage was adjusted until the reversal potential (ERev) was reached, with is the
voltage required to zero the current. This was expanded using larger cis:trans
gradients and was performed with all three rAPOL1 variants. The ERev of an ideal
Ca2+ channel was calculated using the Nernst equation.

Live-cell microscopy
FlpIn TREX APOL1 cells were resuspended in Fluorobrite DMEM (Gibco
A18967-01) with 10% tet-free FBS, 4mM L-glutamine (Gibco 25-030-081), MEM
non-essential amino acids (Gibco 11140-050), and 1mM sodium pyruvate, and then
seeded onto black-walled, optical bottom 96 well plates (Thermo 165305) that were
freshly coated with 2.5µg/cm2 of fibronectin (Sigma F1141). The day after seeding,
cells were transfected with pGP-CMVB-GCaMP6f (Addgene 40755) (Chen et al.,
2013) using Lipofectamine 3000. 6-12 hours after transfection the media was
changed. The day after transfection, APOL1 expressed was induced with 50ng/mL
doxycycline or left untreated. 3µM DRAQ7 (Abcam ab109202) was also added to
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each well to stain dead or membrane-damaged cells. 4-6 hours after induction, cells
were imaged every 10 minutes at 20x.
For RUSH microscopy, HEK293 and CHO-K1 cells were seeded onto glass
bottom 96-well (Grenier 655892) or 24-well (Cellvis P24-1.5H-N) plates in
Fluorobrite DMEM as listed above except with non-tet free FBS. The HEK cells were
seeded onto fibronectin coated wells, whereas the CHO were grown uncoated. Two
days prior to imaging, cells were co-transfected with APOL1 RUSH vectors and one
or two of the following calcium sensors: GCaMP6f and CMV-ER-LAR-GECO1 (61244)
(Wu et al., 2014). The media was changed 6-12h after transfection. On the day of the
experiment, 80µM biotin (Sigma B4639) was added to respective wells and cells
were then imaged every 5 minutes at 10 or 20x. Co-transfections were performed
using 1:1 ratio for both plasmids, while triple transfections were performed using a
2:1:1 ratio of RUSH-APOL1:GCaMP6f:ER-LAR-GECO.
Sensor validations for GCaMP6f and ER-LAR-GECO were performed in FT293
cells the day after transfection. The non-fluorescent Ca2+ ionophore 4-bromoA23187 (Sigma B7272) and the SERCA pump inhibitor thapsigargin (Thermo
T7458) were used.

Immunofluorescence staining
CHO cells were seeded onto glass bottom, 96 well plates and transfected with
RUSH-G0. 2d after transfection, cells were treated with or without 80µM biotin for
2h. For cell surface immunostaining, the plate was moved onto water ice in a cold
room, and the following steps were all performed in the cold room. After cooling for
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10min, cells were washed 3 times with HBSS + Ca2+ + Mg2+ + 1% BSA fraction V, and
blocked in the same solution for 60min. Blocking solution was then replaced with
fresh solution containing primary antibodies mouse anti-APOL1 1:200 and rabbit
anti-calnexin (Stressgen SPA-860) 1:200. Cells were incubated with the primary
antibodies for 1h, followed by 2 quick washes and then 4 x 5min washes. Cells were
washed 1 time with plain HBSS and then fixed with 2% methanol-free formaldehyde
(Thermo 28906) for 20min. Fixing solution was removed and cells were washed 1
time with plain HBSS and then quenched with 50mM NH4Cl for 20min and washed
once more with HBSS. The following steps were performed at room temperature
and away from light. Cells were incubated with secondary antibodies anti-rabbit
Alexa 488 plus 1:500 (Thermo A32731), anti-mouse Alexa 647 1:1,000 (Thermo
A21236), and Hoescht 33342 1:10,000 (Thermo H3570) in blocking solution for
30min. Cells were then washed 2 times quickly followed by 4 x 5min washes. 100µL
of 2,2’-Thiodiethanol (Sigma 166782) was then added to each well. The plate was
covered in parafilm, stored at 4C overnight and imaged the next day.
For permeabilized cell immunofluorescence, all steps were performed at
room temperature. The cells were washed 3 times and then fixed and quenched as
described above. Cells were blocked for 30min with the addition of 0.075% saponin,
which was added to all subsequent solutions. Cells were then incubated with
primary and secondary antibodies, washed, and stored as described above.
Future experiments should modify the amount of Hoescht 33342 used in cell
surface (non-permeabilized) staining, as 1:10,000 yielded a weak nuclear signal.
The recommended starting concentration is 1:1,000.
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Microscopy analysis
To measure the Ca2+ kinetics in individual cells, video files were imported
into Fiji and analyzed with TrackMate (Tinevez et al., 2017). Within an experiment,
the same parameters for spot detection and track linking were applied to each file.
After automated detection, files were manually curated to remove cells that were
dead, overlapping, or those that had migrated out of the field of view (FOV). This
process was applied to every cell within the FOV. A minimum of three files from
replicate wells was analyzed per condition and genotype. For each file, every cell
within the FOV was analyzed. Cells were tracked based upon the fluorescence of the
Ca2+ sensor. The raw data was then exported and analyzed with R to determine the
change in mean fluorescence intensity for each cell using the following equation:

(FluorescenceTime=X – FluroescenceTime=0) / FluroescenceTime=0 = ∆F/F0

where F0 is the average mean fluorescence of the first 3 timepoints for each cell.
In order to quantify the amount of cells that exhibited a significant increase
in intracellular Ca2+ and differentiate them from cells undergoing transient Ca2+
signaling, we created a ∆F/F0 threshold. This threshold was determined by manually
analyzing control cells (G0, uninduced or no biotin) for each experiment. The
threshold was dependent on the cell type, objective, and sensor(s) used. In order for
a cell to be counted as positive for a significant Ca2+ influx, the ∆F/F0 of the cell had
to be above the threshold for a minimum of 5 timepoints.
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For dual color tracking, the multi-channel tracking plug-in was used in
TrackMate, which allows for the tracking of cells in one channel (GCaMP6f) while
collecting data from all other channels (DRAQ7, ER-LAR-GECO).
The following TrackMate settings and ∆F/F0 thresholds were used for livecell Ca2+ influx experiments with GCaMP6f:

Immunofluorescence analysis for APOL1 signal at the cell surface was
performed in Fiji. The mean fluorescence intensity of the entire FOV was quantified
using a maximum intensity projection, and a minimum of 10 FOVs were analyzed for
each condition. For co-localization of APOL1 and calnexin, images were loaded into
Icy and maximum intensity projections were generated for analysis. Individual cells
were highlighted and then the spot detector tool was used in combination with the
tracking program to calculate percent co-localization.
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Microscopes
For live-cell microscopy, a widefield setup was used. Live imaging was
performed with a Ziess Axio Observer with 470, 555, or 625nm LED excitation along
with Zeiss filter cubes 38 (green), 20 (red), and 50 (far-red). Recording was
performed using a sCMOS with 6.5µm pixels (Hamamatsu Flash4.0v2). Live
experiments were performed within an incubation chamber at 37C with 5% CO2 and
humidity.
For immunofluorescence, spinning disk confocal microscopy was used. A
Zeiss Axio Observer was fitted with a Yokogawa CSU-X1 spinning disk head.
Excitation was performed with 405, 488, 561, or 639nm laser. Recording was
performed using a back-thinned EMCCD camera with 16µm pixels (Photometrics
Evolve512).

In vivo mouse challenge and HDL purification
In vivo mouse challenges were performed using 20-25g female SwissWebster mice. Hydrodynamic gene delivery (HGD) of 50µg of empty or APOL1
PRG977 vectors was performed by tail vein injection (27 gauge syringe) using 23mL saline (10% body weight). Two days after injection each mouse was infected
with 5,000 Trypanosoma brucei 427 parasites via intra-peritoneal injection. Every 23d, 20µL tail vein blood samples were collected to monitor parasitemia. Mice were
euthanized if parasitemia reached 1*10^9 parasites/mL. All trypanosome
experiments were performed in a biosafety level 2 laboratory.
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To analyze circulating APOL1 levels, mouse serum was prepared from tail
bleed samples two days after HGD injection by centrifugation with serum separators
(BD 365956) at 6,000 x g for 1-2min. To analyze APOL1 association with HDL, mice
were injected via HGD and whole serum was collected after 2d. Murine HDL was
purified as previously described (Molina-Portela et al., 2008). Serum and purified
HDL were diluted 1:40 in Laemmli buffer and run on 10% Tris-glycine SDS PAGE
gels. Chemiluminescent immunoblots were performed using anti-APOL1 1:10,000,
anti-APOA1 1:10,000 (Abcam ab20453), and anti-rabbit True Blot-HRP 1:2,500
(Rockland 18-8816-33).
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Chapter 1
Assessing the Function of the APOL1 BH3 Domain and the
Cytotoxicity of the APOL Family Members
Introduction
The cytotoxicity of APOL1 has been linked to autophagic cell death (ACD)
(Wan et al., 2008). Many studies have reported detection of autophagy after APOL1
overexpression (Beckerman et al., 2017; O'Toole et al., 2018; Olabisi et al., 2016).
However, the mere presence of autophagic turnover occurring during cell death
does not mean that it is the cause (Kroemer and Levine, 2008). Autophagy and ACD
can be regulated by BH domain containing proteins (Maiuri et al., 2007a), and in
silico prediction revealed that APOL1 contains a single BH3 domain (Wan et al.,
2008).
Deletion of the APOL1-G0 BH3 domain (APOL1.∆BH3) completely rescued
the human colon cancer DLD1 cells from APOL1 cytotoxicity, as did treatment with
chemical autophagy inhibitors such as wortmannin. Overexpression of APOL1 in
mouse embryonic fibroblasts (MEFs) that had autophagy related gene (ATG) 5
knocked out were partially rescued from cytotoxicity as well (Wan et al., 2008).
These data suggested ACD as a mechanism of APOL1-mediated cell death. However,
the methods used left results open to an alternative interpretation. Chiefly, deletion
of the nine-amino acid sequence representing the BH3 domain was likely
deleterious to normal protein function. Rather than outright deletion, alanine
scanning is typically used to modulate BH domain function, as these amphipathic
helices directly facilitate protein:protein interactions (Day et al., 2008). Additionally,
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cytotoxicity in MEFs was represented with low quality bright-field microscopy that
was difficult to discern. We therefore hypothesize that deletion of the BH3 domain
would be deleterious to APOL1 function, and sought to determine the roles
autophagy and the BH3 domain have in APOL1 cytotoxicity.
The APOL cluster represents a family of potential innate immunity genes
(Smith and Malik, 2009). Their close relation due to recent duplications suggests the
possibility of similar properties and functions. Indeed, all are induced by proinflammatory cytokines such as IFNs. Additionally, APOL2 and 6 are also predicted
to contain BH3 domains, and overexpression of APOL6 is pro-apoptotic and
cytotoxic in DLD1 cells, whereas APOL2 may be anti-apoptotic in human bronchial
epithelial cells (Liao et al., 2011; Liu et al., 2005). We hypothesize that other
members of the APOL family may be cytotoxic when overexpressed, and aim to
compare possible mechanisms leading to cell death, including channel-forming
capabilities.

Results
The Putative BH3 Domain of APOL1 is Dispensable for Cytoxicity and
Trypanolysis
We first aimed to determine if deletion of the BH3 domain rendered APOL1
non-functional. The in silico prediction of the APOL1 BH3 domain is a nine-amino
acid region just upstream of the first predicted transmembrane domain. The
residues maintained in all BH3 domains are L158 and D163, with R159 also strongly
conserved (Figure 2A) (Kelekar and Thompson, 1998). We converted all three
residues to alanines individually and in a triple mutant (APOL1.triplemut). To test
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APOL1 function, we challenged HGD mice expressing APOL1 or the indicated BH3
mutants with T. brucei.
All mice expressing APOL1.∆BH3 were killed by infection with T. brucei
within 11 days 2 days earlier than those injected with empty vector (not significant).
Mice expressing APOL1.WT and any of the BH3 single or triple point mutations were
completely protected for 30 days (Figure 2B and C). This demonstrates that the BH3
domain is dispensable for trypanolysis, and that deletion of the entire region
renders APOL1 non-functional. HDLs were purified from mouse serum two days
after HGD injection to ensure that manipulation of the BH3 domain did not affect
association of APOL1 with HDL. Indeed, mutation or deletion of the BH3 domain had
no effect on HDL association, as APOL1 was detected via immunoblot in the 1.01.25g/ml density fraction of serum that contained APOAI (Figure 2D).
We next tested to see if the BH3 domain was required for cytotoxicity in
human HEK293 cells. Transient overexpression of APOL1.WT was cytotoxic, leading
to approximately 50% cell death after 48h, while APOL1.∆BH3 led to no measurable
cell death (Figure 2E). Importantly, overexpression of APOL1.triplemut was also
cytotoxic, albeit ~30% less than APOL1.WT (Figure 2F). This indicates that the BH3
domain is largely dispensable for toxicity in mammalian cell lines, but the helix of
which it is part is essential. This is consistent with the study published along with
our collaborators, where APOL1 single and triple BH3 mutations (using V165
instead of R158) had no effect on cytotoxicity in cRNA injected oocytes. Even
overexpression of APOL1 with the entire nine-amino region converted to alanines
was cytotoxic, albeit significantly reduced. Finally, treatment of oocytes with the
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chemical inhibitor of autophagy wortmannin had no effect on cytotoxicity
(Heneghan et al., 2015). These data demonstrate that the putative BH3 domain is
not required for APOL1 cytotoxicity and that ACD does not occur.
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Assessing the Cytotoxicity of the APOL Family
The APOL gene cluster encodes a family of potentially cytotoxic proteins. As
little is known about the structure or function of APOL2-6, we began with a
comparison of linear structure. Kyle-Doolittle hydropathy plots were used to
compare the number and location of predicted transmembrane domains (Figure
3A). The plots revealed that APOLs 1-4, the primate-specific cluster that arose most
recently due to duplication, contain 2-3 predicted transmembrane domains in the
same locations, including at the C-terminus. This suggests that, like APOL1, APOL2-4
can potentially form ion channels. APOL5 and 6 also contain 1-2 transmembrane
domains, but in different regions. We next compared the cytotoxicity of APOL1-6.
APOL1, 3, 4, and 6 are cytotoxic when overexpressed in HEK293 cells,
whereas APOL2 and 5 are not (Figures 3B and 3C). APOL3 was the most cytotoxic
leading to nearly 80% cell death and led to a swollen cell phenotype similar to
APOL1. This was followed by APOL6, which caused approximately 60% cell death
and led to a condensed cell phenotype consistent with apoptosis (Figure 3F). APOL1
and 4 were similarly toxic, but no cell morphology changes were observed with
APOL4. Analysis of the amino acid sequences of APOL1-6 for localization signals
revealed that APOL4 contains a putative signal peptide. For APOL1, the signal
peptide, and therefore trafficking through the secretory pathway, was required for
cytotoxicity, as the intracellular isoform did not cause any cell death (Figure 3D).
For APOL4, expression of the isoform lacking a signal peptide led to a modest
reduction in toxicity (Figure 3E). It is unclear if the predicted signal peptide of
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APOL4 is functional, and we were unable to test for secretion or localization due to
lack of an antibody.
There is a lack of commercially available antibodies for APOL2-6. Therefore,
in order to perform immunoprecipitation and localization studies, as well as directly
compare expression levels, we tagged APOL1-6. Myc or 3xFLAG tags were added to
the N-terminus of the APOLs along with a flexible 2xGGSGG linker. For the APOL1
isoform containing a signal peptide, the tags were inserted downstream of the signal
peptide cleavage site. Cytotoxicity of APOL1 was largely unaffected by the Nterminal myc tag (Figure 3A). Unfortunately, the cytotoxicity of APOL3, 4, and 6 was
reduced by up to 5-fold due to tagging (Figures 3B, 3C, and 3D). Tagging of the Cterminus was avoided due to its importance in APOL1 channel assembly and
possible oligomerization, and a C-terminal fusion of GFP to APOL1 completely
abrogated cytotoxicity (Figure 3E). A C-terminal myc tag will be more tolerable than
a GFP and will be utilized for future experiments.
Due to similarities in cytotoxicity and predicted structure to APOL1, we
hypothesized that APOL2-6 could also form ion channels. Planar lipid bilayer
experiments and purifications were performed as with rAPOL1. Only rAPOL3 and 4
could be purified with this method, and both formed ion channels (Data not shown.
Experiments performed by Russell Thomson). rAPOL3 could both insert into the
membrane and conduct ions at neutral pH. Like rAPOL1, rAPOL3 is cation-selective.
rAPOL4 also functioned at neutral pH, with the added requirement of a positive
voltage to drive insertion. These data confirm our hypothesis that the human APOL
gene family encodes cytotoxic, channel forming proteins.
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Discussion
The Putative BH3 Domain of APOL1 is Dispensable for Cytotoxicity
Using a combination of in vivo and in vitro techniques, we report that the
putative BH3 domain is dispensable for cytotoxicity and that deletion of the nineamino acid region renders the protein non-functional. This was confirmed by an in
vivo mouse challenge, where APOL1.∆BH3 provided no immunity against the animal
infective T. brucei. In HGD mice, APOL1.∆BH3 was associated with circulating HDL
particles, indicating that the deletion likely affected channel formation. APOL1.∆BH3
was also not toxic when overexpressed in HEK293 cells, unlike APOL1.triplemut,
which contained point mutations that would render a classical BH3 domain nonfunctional. Our collaborators corroborated these results by overexpressing APOL1
with the entire BH3 domain substituted for alanines. This 9-alanine mutant
remained cytotoxic, albeit reduced compared to WT. These results suggest that the
cytotoxicity of APOL1 is not due to the putative BH3 domain.
Activation of autophagy has been observed in many different cell types
expressing APOL1. However, attempts at inhibiting autophagy, outside of the
original study by Wan et al, failed to have rescue cytotoxicity (Heneghan et al., 2015;
O'Toole et al., 2018; Olabisi et al., 2016). Additionally, autophagy may simply due to
expression of APOL1 and not because of its cytotoxic effects. Overexpression of
APOL1-G1 and G2 led to K+ efflux in stably transfected TREX293 that preceded cell
death, and this cytotoxicity could be rescued by culturing cells in media containing
high K+ in place of Na+. Even with the prevention of cell death, autophagy was still
detected (Olabisi et al., 2016). Therefore, while the activation of autophagy by
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APOL1 may play an important role in the cell, it is not the pathway that causes cell
death.
The amphipathic helix of the BH3 domain is used to direct binding to other
BH-domain containing proteins (Kelekar and Thompson, 1998). Co-expression of
Beclin-2, which negatively regulates autophagy by binding the BH3 domain of
Beclin- 1 (Maiuri et al., 2007b), had no effect on APOL1 cytotoxicity. Interestingly,
co-expression with other BH-domain containing proteins, such as the anti-apoptotic
myeloid leukemia (Mcl)-1, rescued APOL1 cytotoxicity. However, attempts to
immunoprecipitate overexpressed Mcl-1 and APOL1 were not successful, indicating
that this rescue was not due to direct binding via BH domains (Heneghan et al.,
2015). The mechanism underling Mcl-1 mediated from APOL1 rescue remains
unknown, however it is unlikely to occur via BH3 domain interaction.
Further evidence demonstrating that APOL1 does not contain a functional
BH3 domain comes from the cytotoxicity of APOL1.triplemut. Protein:protein
interactions mediated by BH3 domains can be abrogated by alanine point mutations
in conserved residues, and APOL1.triplemut contains alanines in the three most
conserved BH3 residues. However, while this is not a functional BH3 domain, it may
still be integral for cytotoxicity and trypanolysis. Overexpression of APOL1 with the
entire region substituted for alanines significantly reduced cytotoxicity.
Additionally, substituting two glutamic acids or lysines for hydrophobic residues in
the region completely prevented trypanolysis with rAPOL1 (Vanwalleghem et al.,
2015). However it should be noted that APOL1 is highly sensitive to small changes
in other domains as well, which can be seen in the case of G1 and G2, where a two

54

amino acid substitution or deletion at the C-terminus leads to immunity against
human-infective trypanosomes.
To continue this study, the channel properties of the BH3 mutants and
deletion should be tested in planar lipid bilayer experiments. This would reveal
whether the BH3 deletion affects channel assembly, seen as the initial current after
acidic insertion, or channel opening. In order to further test our hypothesis that the
BH3 is expendable for APOL1-mediated cytotoxicity, APOL1 and APOL2 chimeras,
the latter of which lacks a putative BH3 domain, can be generated and tested for
cytotoxicity. Additionally, the ability of Mcl-1 to rescue APOL1 cytotoxicity should
be pursued further in mammalian cell lines with functional programmed cell death
pathways. Finally, immunoblots need to be performed for transfected HEK293 cells
to compare protein expression.
Following our study and that of our collaborators, we conclude that APOL1
does not contain a functional BH3 domain, and that APOL1 does not induce ACD.

The APOL Gene Family
Utilizing an overexpression system we describe the APOL gene cluster as
encoding a family of cytotoxic, channel forming proteins. APOL1, 3, 4, and 6 led to
cell death, with APOL3 and 6 being the most toxic. APOL3 led to a swollen cell
phenotype also observed with APOL1, consistent with necrosis and osmotic
swelling. Meanwhile, APOL6 led to a condensed cell phenotype that is congruent
with apoptotic cell death. APOL1-4 have predicted transmembrane domains in the
same regions, suggesting the ability to form ion channels like APOL1. Indeed, we
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discovered that rAPOL3 and 4 formed ion channels in planar lipid bilayers. Finally,
we report that N-terminal tagging of the APOLs is deleterious for function.
These results allow us to hypothesize the intracellular function and
localization of the APOLs. APOL3 can form cation-selective channels similar to
APOL1 without the requirement for pre-acidification, indicating that cytotoxicity
likely occurs from the cytoplasm. APOL4 requires a positive voltage for membrane
insertion, and as the cytoplasm generally contains a negative voltage across the
plasma and organellar membranes, this suggests that toxicity of APOL4 occurs
elsewhere in the cell, possibly within organelles. Finally, APOL6 has been reported
to induce apoptotic cell death (Liu et al., 2005), suggesting it may localize near the
mitochondria, where other pro and anti-apoptotic proteins are typically found.
To further this study, APOL1-6 will be tagged at the C-terminus to directly
compare protein expression levels and to perform and co-immunoprecipitation
studies. Utilizing the tagged proteins, we can assay for co-localization with various
intracellular markers to determine localization. Combinatorial expression of
differentially tagged APOLs will allow us to assay for direct interactions and
modulation of cytotoxicity. It has already been reported that overexpressed APOL1
and 3 interact (Skorecki et al., 2017). Additionally, APOL2 has been reported to be
anti-apoptotic (Liao et al., 2011), suggesting plausible interaction with APOL6. We
will also attempt to purify APOL2, 5 and 6 and test for their potential to form ion
channels. Finally, to determine the mechanisms underlying their toxicity, we will
assay for the activation of various cell death pathways. Importantly, these
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experiments must be done in cells competent for these mechanisms, such as bone
marrow derived macrophages from mice.
The APOL gene family remains largely untouched by research. A combination
of strong positive selection in the primate lineage along with their induction by proinflammatory cytokines strongly suggests that they play an important role in innate
immunity. Elucidation of their functions immunity has already begun, as APOL6 was
discovered to restrict poliovirus infection (Schoggins et al., 2014), and coexpression of APOL1 with HIV cDNA in HEK293 cells limited viral infectivity (Taylor
et al., 2014). The other APOLs may also contribute to host defense, and due to their
cytotoxic and channel forming properties, may do so by regulating a variety of cell
death pathways. This study contains the potential to significantly increase our
understating of the APOLs and stimulate interest for further research.
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Chapter 2
APOL1-G1 and G2 Form Ca2+-Permeable Channels at the
Plasma Membrane that Lead to Cell Death
Introduction
The mechanism underlying the cytotoxicity of G1 and G2, and thereby kidney
disease, remains unknown. Multiple cell death mechanisms have been invoked, and
there is little consensus on which ones drive disease. However, while these
mechanisms seem disparate, most can be linked as a cellular response to PFTs. PFTs
will activate multiple intracellular signaling and inflammatory pathways depending
on their mechanism of action (Cancino-Rodezno et al., 2010; Porta et al., 2011). As
APOL1 forms cytotoxic channels in trypanosomes, we assessed whether it would kill
mammalian cells via a similar mechanism.
There is evidence that APOL1 forms cation-selective channels in animal cells,
mirroring its activity in trypanosomes. Patch-clamping of TREX293 or Xenopus
oocytes revealed that overexpression of APOL1 leads to a current across the PM that
can be inhibited by an acidic pH below 6.0. APOL1 also led to the dissipation of
cellular Na+ and K+ gradients in TREX293 cells (O'Toole et al., 2018). Interestingly,
overexpression of APOL1 in oocytes led to an intracellular accumulation of 45Ca2+
(Heneghan et al., 2015). While APOL1 channel activity and cytotoxicity regarding
Na+ and K+ have been well studied, we were interested in determining what role the
potent intracellular messenger Ca2+ plays. Additionally, we wanted to further
elucidate the events and kinetics that lead to APOL1-mediated cell death, as well as
the intracellular requirements necessary for channel formation.
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Results
Expression of APOL1 in FlpIn TREX293 Stable Cell Lines Represents a Relevant
Cell Culture Model of APOL1-Mediated Kidney Disease
FlpIn TREX 293 (FT293) cell lines stably expressing a single copy of
doxycycline-inducible APOL1 G0, G1, or G2 variant cDNA, or empty vector cDNA
were generated. The alleles of each APOL1 variant used are the most prevalent in
the human population as indicated in Figure 5A. Each cell line contained similar
amounts of APOL1 protein after 4h induction with 0.05-50ng/mL doxycycline
(Figure 5B). Increasing the induction time led to a significant increase in
cytotoxicity, as measured by LDH release, in FT293-G1 and G2, but no G0, cells after
20h of expression, with 20-25% cytotoxicity observed after 36h (Figure 5C).
Additionally, we find that expression of G2 kills cells more rapidly than G1, as seen
after 20-28h of induction.
It has recently been proposed that overexpression in human cell lines is not
physiologically relevant (O'Toole et al., 2018). However, O’Toole et al did not
establish a physiological amount of APOL1 expression for comparison. In order to
perform this comparison, conditionally immortalized podocytes (Saleem et al.,
2002) were stimulated with 0.1-100ng/mL IFNγ for 24h to induce APOL1
expression (Figure 6A). 10ng/mL IFNγ induced maximum APOL1 expression in
podocytes and was compared to FT293-G0 cells induced with 0.08-0.2ng/mL of
doxycycline for 24h (Figures 6B).
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0.2ng/mL of doxycycline led to a comparable amount of APOL1 protein expression.
Inducing FT293-G1 and G2 cells with 0.2ng/mL doxycycline led to cell swelling
within 24h (data not shown), 5 and 10% cytotoxicity by 48h, and 10 and 15%
cytotoxicity by 72h, respectively. (Figure 6C). These findings indicate that the G1
and G2 induced cytotoxicity in FT293 cells occurs with a physiological amount of
expression, and represents a relevant cell culture model of APOL1-mediated chronic
kidney disease.
The APOL1 Channel Conducts Ca2+
A previous study indicated that overexpression of APOL1 in Xenopus oocytes
led to an influx of Ca2+ and cytotoxicity (Heneghan et al., 2015). To investigate
possible links between APOL1 expression, Ca2+ flux, and cytoxicity we evaluated if
the APOL1 channel itself could conduct Ca2+; Only Na+ and K+ permeability have
been demonstrated (del Pilar Molina-Portela et al., 2005; Thomson and Finkelstein,
2015). In the latter study APOL1 was shown to insert into planar lipid bilayers at
acidic pH, but opening of K+ permeant channels required subsequent pH
neutralization. Here we replaced KCl with equimolar CaCl2 on both sides of the
bilayer and show that all three APOL1 variants exhibit a similar pH-sensitive
conductance, enhanced approximately 450-fold upon pH neutralization (Figure 7A).
To examine ion selectivity of this conductance, we determined the reversal potential
(Erev, the voltage required to zero the current), before and after addition of CaCl2 to
the cis side to establish a 1.95-fold cis:trans CaCl2 gradient. Erev became more
negative after CaCl2 addition (changing from -1 mV to -6 mV), indicating selectivity
for Ca2+ over Cl-. By measuring Erev at multiple cis:trans CaCl2 gradients we
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established that recombinant APOL1 variants G0, G1, and G2 were similarly
permeable to Ca2+ (Figure 7B). These data show that APOL1 channels are permeable
to Ca2+ and could directly result in cellular Ca2+ flux.
The Cytotoxicity of APOL1 Requires Ca2+
We tested the role that Ca2+ may play in APOL1 cytotoxicity by altering the
concentration of Ca2+ outside of the cell. Extracellular CaCl2 was adjusted from 04mM (neglecting the ~0.2-0.4mM contributed by 10% serum), and then FT293 cells
were induced with 50ng/mL doxycycline for 24h. There was a positive linear
relationship between extracellular Ca2+ and cytotoxicity, with APOL1-G1 and G2
cytotoxicity diminished approximately 4-fold with 0-1mM CaCl2, followed by 0.5fold increase at 4mM CaCl2 (Figure 7C). Even with increased extracellular Ca2+,
however, FT293-G0 remains non-toxic.
To ensure that the cytotoxic effect was specific to Ca2+, cells were cultured in
media containing 2mM CaCl2 that was chelated with 1.0-1.5mM EGTA. After 24h of
APOL1 expression, cytotoxicity in FT293-G2 cells was reduced approximately 50%
with the addition of EGTA. To test whether this result could be reproduced with
another biologically relevant divalent cation, cells were cultured in the presence of
0.9-3.6mM MgCl2. However, increased Mg2+ had little effect on cytotoxicity (Figure
8), illustrating that this phenomenon is Ca2+-specific. These results suggest a pivotal
role for Ca2+ in promoting APOL1 cytotoxicity, though the requirement for Ca2+
influx and its kinetics must be determined.
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Expression of G1 and G2, but not G0, Leads to an Increase in Intracellular Ca2+
that Precedes Cell Swelling and Membrane Damage.
APOL1 has been shown to cause a flux of ions across the PM when
overexpressed in HEK293 cells or incubated with trypanosomes (del Pilar MolinaPortela et al., 2005; O'Toole et al., 2018; Rifkin, 1984), indicating that it forms active
ion channels within the cell. It also leads to a cell swelling phenotype in both
instances that precedes cell death. In trypanosomes, this is due to a colloidal
osmotic effect caused by an increase of intracellular ions, which leads to the influx of
H20 through aquaporins. We hypothesize that expression of APOL1 leads to ion
channel formation, which causes an influx of Ca2+ that precedes cell swelling and
death.
To study Ca2+ flux and its kinetics, FT293 cells were transfected with the
fluorescent calcium indicator GCaMP6f, which provides a real-time fluorescent
readout of cytosolic Ca2+ levels (Chen et al., 2013). When expressed in cells,
GCaMP6f exhibits low fluorescence that is increased upon an influx of Ca2+, as
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demonstrated by treatment with a Ca2+ ionophore (Figure 9, Movie 1). To mark cells
that have experienced large-scale membrane damage or undergone lysis, the cellimpermeable DNA dye DRAQ7 was used.
FT293-G1 and G2 cells, but not G0, exhibit a large increase in cytosolic Ca2+
beginning approximately 12-18h after induction of APOL1 expression with 50ng/mL
doxycycline (Figure 10, Movie 2). Ca2+ influx in cells expressing G1 and G2 increases
gradually over several hours and occurs prior to cell swelling, large changes in cell
morphology, or membrane blebbing (Figures 11A, 11B and 11C). The cells typically
remain swollen for 12-18h before lysis. The kinetics towards lysis are measurably
slower than when cytotoxicity alone was measured (Figure 5C), possibly due
transfection with the GCaMP6f plasmid. DRAQ7 was only detected after cell lysis,
indicating that there is no large, non-specific damage to the plasma membrane that
allows for Ca2+ influx. On average, FT293-G2 cells displayed earlier Ca2+ influx and
swelling compared to G1, in agreement with the findings of faster killing kinetics in
Figure 5C.
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High-throughput microscopy and analysis was performed to rigorously
compare the Ca2+-dependent fluorescence change in each cell line with and without
doxycycline induction, as outlined in Experimental Procedures. A GCaMP6f based
fluorescence threshold was established based on the ∆F/F0 observed in uninduced
FT293-G0 cells. Expression of G1 and G2 led to an approximately 4-fold increase in
the percentage of cells above the Ca2+-dependent fluorescence threshold compared
to both G0 and uninduced cells (Figures 11D and 11E). Expression of G0 did not lead
to a measurable increase in cytosolic Ca2+. These data confirm that expression of G1
and G2 leads to an influx of extracellular Ca2+ into the cytosol that precedes cell
swelling and death, however it does not confirm that this is occurring directly
through APOL1 ion channels at the PM.
The Cytotoxicity of APOL1 Requires Trafficking from the Endoplasmic
Reticulum
To ascertain whether or not APOL1 itself is driving the Ca2+ influx as an
active ion channel at the PM, we utilized the Retention Using Selective Hooks
(RUSH) system to control and synchronize APOL1 trafficking (Boncompain et al.,
2012). The RUSH system utilizes a streptavidin localized to the ER, which binds to
the target protein that is tagged with a streptavidin binding peptide (SBP) (Figure
12A). Therefore the protein builds up in the ER after transfection, and is then
synchronously released by addition of biotin to the culture media. As the major
isoform of APOL1 contains a signal peptide and localizes to the ER, APOL1 cDNA was
cloned into the RUSH system to determine whether toxicity was due to localization
in the ER or trafficking from it.
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HEK293 cells transfected with RUSH-APOL1 were completely protected
against the cytotoxicity when G1 and G2 were retained in the ER, which has a
neutral pH (Figure 12B). However, upon treatment with biotin and subsequent
trafficking from the ER, a 20% increase in cytotoxicity was observed. The
cytotoxicity of RUSH-G1 and G2 was also exacerbated 2-3-fold by increasing the
extracellular Ca2+ concentration to 4 and 8mM (Figure 13A), similar to in FT293
cells (Figure 7C).
RUSH-G1 exhibits toxicity with slower kinetics relative to G2 from 6-12h
after biotin addition, which is comparable to the results in the FT293 cells (Figure
5C). When retained in the ER, RUSH-G0, G1, and G2 express at similar levels (Figure
12C top panel). However, after biotin-mediated release G0 and G2 protein levels are
reduced by approximately 50%, compared to 20-25% in G1, indicating a difference
in trafficking kinetics or protein turnover (Figure 12C bottom panel).
A parallel attempt to retain APOL1 in the ER and prevent cytotoxicity was
performed by adding C-terminal KDEL (luminal) or KKXX (cytoplasmic) retention
signals (Pelham, 1990; Vincent et al., 1998). However, the toxicity of transiently
overexpressed APOL1-G0 in HEK293 cells was unaffected by either KDEL or KKXX
(Figure 14A). Pull-down of biotinylated cell-surface proteins revealed similar levels
of APOL1, APOL1:KDEL, and APOL1:KKEL at the PM (Figure 14B), demonstrating
that APOL1 could not be held back in the ER with these C-terminal retention signals.
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APOL1-Mediated Ca2+ Influx Requires Trafficking from the ER.
When expressed in stably transfected cells, APOL1 G1 and G2 led to an influx
of cytosolic Ca2+ that preceded cell swelling (Figures 11A, 11B, 11C, Movie 2). We
aimed to determine if this phenotype would be observed with the RUSH system, and
if the Ca2+ influx would require trafficking of APOL1 from the ER. Expression of
RUSH-G1 and G2 in HEK293 cells led to a rapid increase in cytosolic Ca2+, as
measured when co-expressed with GCaMP6f, which occurs before cell swelling. This
phenomenon is dependent upon release of APOL1 from the ER (Figure 15, Movie 3),
and displays faster kinetics when compared to the expression of APOL1 in stably
transfected FT293 cells, as Ca2+ influx and cell swelling occur within 2-6h of biotin
addition. Importantly, DRAQ7 staining occurred only after the cells had ruptured
(Figures 12D, 12E, 12F, 15, Movie 3).
High-throughput analysis was performed as before, with the analysis limited
to 8h after biotin addition, as all cell swelling events occurred within that timeframe.
There is an approximately 3-fold increase in the amount of cells above the Ca2+dependent fluorescence threshold when G1 and G2 are treated with biotin,
demonstrating that the Ca2+ influx is dependent upon APOL1 trafficking from the ER
(Figure 12G and 12H). The Ca2+ influx due to RUSH-G1 and G2 trafficking from the
ER was reproduced in CHO cells (Figures 13B, 13C, 16, Movie 4). These data
demonstrate that the RUSH system faithfully reproduces the results observed in the
stably transfected FT293 cells, but with faster kinetics and the ability to synchronize
APOL1 trafficking.
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APOL1 Localizes to the PM after Release from the ER
Endogenous APOL1 traffics to the PM in IFNγ-stimulated podocytes (Scales
et al., 2017), and PM localization was also described in TREX293 cells
overexpressing APOL1 (O'Toole et al., 2018). We aimed to determine whether
RUSH-APOL1 traffics to the PM after addition of biotin, and if localization to the PM
occurs within a timeframe before Ca2+ influx is first detected. While there is cell-tocell variability, Ca2+ influx typically occurs within 2-4h of biotin treatment in CHO
cells overexpressing RUSH-G1 or G2 (Figure 16, Movie 4).
Cell surface immunostaining of APOL1 revealed a significant increase in
RUSH-G0 localization at the PM after 2h of biotin treatment, which is within the
timeframe of observed Ca2+ influx for G1 and G2, and displays punctate staining
(Figure 17A). Quantification of mean fluorescence intensity revealed a 6-fold
increase in APOL1 signal at the cell surface after biotin-mediated release (Figure
17B). Several cells without biotin treatment display weak APOL1 staining, indicating
a leak from the ER, however the signal is significantly lower compared to biotin
treated cells. Cell surface immunostaining was subsequently performed on RUSH-G1
and G2 90min after biotin addition, revealing similar punctate staining at the PM
between the APOL1 variants (Figure 17C). Intracellular RUSH-APOL1 co-localizes
with the ER marker calnexin in untreated cells, with no detectable APOL1 at the PM
(Figure 18A). 1h post biotin treatment, APOL1 was detected at the PM for all
variants (Figure 18B, top panel, arrows), with the majority of APOL1 remaining in
the ER. 2h after biotin-mediated release, RUSH-APOL1 was robustly detected at the
PM in all variants (Figure 18C), corroborating the cell surface immunostaining
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(Figure 17). At this timepoint, RUSH-G1 and G2 led to cell swelling in nearly all
transfected cells, which was characterized by a rounded and bulging PM along with
ER retratction from the PM . These results demonstrate that RUSH-APOL1 traffics to
the PM before Ca2+ influx is first detected, suggesting that G1 and G2 form cytotoxic
cation channels at the cell surface.
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Extracellular Ca2+ is the Source for G1 and G2-Mediated Influx and Cytotoxicity
The ER is the largest reservoir of intracellular Ca2+, and release of ER Ca2+
stores plays a pivotal role in many signaling and cell death pathways (Prakriya and
Lewis, 2015). In order to determine if ER Ca2+ release plays a role in APOL1mediated Ca2+ influx and cytotoxicity, GCaMP6f was co-transfected with the ER Ca2+
sensor ER-LAR-GECO (Wu et al., 2014). Treatment of cells with the SERCA inhibitor
thapsigargin causes Ca2+ that was destined for ER uptake to build up in the cytosol,
and can be measured by the combination of sensors (Figure 19, Movie 5). CHO cells
were co-transfected with these sensors as well as RUSH-APOL1. Cells exhibiting the
established phenotype of cytosolic Ca2+ increase and swelling following biotin
treatment were analyzed for changes in ER-LAR-GECO fluorescence. We found that
while the cytosolic Ca2+ increases, there is no release of Ca2+ from the ER (Figures 20
and 21, Movie 6). Rather, the ER Ca2+ levels remain steady or increase slightly in
conjunction with the rise in cytosolic Ca2+, possibly as an attempt to reduce the Ca2+
buildup. However, the increase of ER Ca2+ is inconsistent between cells. The lack of
ER Ca2+ release indicates that the source of Ca2+ in APOL1 cytotoxicity is
extracellular, and is likely conducted through G1 and G2 cation channels at the PM.
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Regulation Along the Secretory Pathway Likely Prevents G0 Cytotoxicity
Pre-acidification is a requirement for rAPOL1 to form a functional channel, as
it likely drives oligomerization. As G0, G1, and G2 form channels that are equally
permeable to Ca2+, we hypothesized that G0 is not cytotoxic due to regulation along
the secretory pathway that prevents acid-driven oligomerization. To circumvent
this potential regulation and drive G0 channel formation, we allowed RUSH-G0 and
G2 to traffic to the PM with 4h of biotin treatment. After PM localization, we
acidified cells for 1h at pH 5.5, followed by neutralization and 24h incubation.
Acidification of PM-localized RUSH-G0 led to a 2.5-fold increase in cytotoxicity
compared to RUSH-G0 retained in the ER (Figure 22). Surprisingly, acidification of
cells with RUSH-G2 retained in the ER led to an approximately 4-fold increase in cell
death compared to no acid. This is likely due to the leakiness of the RUSH combined
with acid increasing the channel forming potential of APOL1. Additionally,
acidification of cells will also lower the pH of the cytosol and organelles, potentially
activating APOL1 throughout the cell.
These results suggest that regulation along the secretory pathway prevents
G0 oligomerization and therefore cytotoxicity, perhaps in the form of an SRA-like
chaperone that binds G0 with higher affinity than G1 or G2. G1 and G2 can evade
this interaction and form Ca2+-permeable channels at the PM, leading to cell death
and disease (Figure 23 A and B).
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Discussion
A comprehensive analysis using a number genetic, biochemical, and
microscopy-based approaches revealed that the cytotoxicity of G1 and G2 requires
trafficking from the ER to the PM, where it causes a cytotoxic influx of Ca2+. Using
electrophysiology to study rAPOL1 channel selectivity, we were able to demonstrate
that the channel is permeable to Ca2+, suggesting that APOL1 directly leads to the
observed Ca2+ influx. While G0, G1, and G2 were equally permeable to Ca2+, G0 was
not toxic in our expression systems. However, it too led to cell death if acidified and
neutralized after PM localization. This supports our hypothesis that acidification
along the secretory pathway is essential for cytotoxicity, and suggests a regulatory
mechanism or chaperone along this route that prevents channel formation of G0,
but not of G1 and G2. Finally, as Ca2+ is a potent signaling molecule that can activate
many signaling and cell death pathways (Lee et al., 2012b; Zhivotovsky and
Orrenius, 2011), we propose that the APOL1-mediated Ca2+ influx is the upstream
event linking the many APOL1-associated cell death pathways together.
We first replicated previously reported results that G1 and G2, but not G0,
lead to cytotoxicity when expressed in FT293 cells (Figure 5C) (Olabisi et al., 2016).
The cytotoxicity was marked by membrane blebbing and a swollen cell phenotype
(Figures 10, 15, 16, Movies 2, 3, and 4), the latter of which is also observed in TLF or
human serum treated trypanosomes. Importantly, we used the naturally occurring
alleles of G0, G1, and G2 (Figure 5A). A study by O’Toole et al reported that all three
variants were equally cytotoxic, however in their approach they added the Cterminal mutations to the G4 allele (Figure 5A). The lytic activity of APOL1 is highly
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sensitive to even single amino acid changes (Cuypers et al., 2016), highlighting the
importance of using the naturally occurring alleles to draw relevant conclusions on
APOL1 cytotoxicity and disease.
We are the first to report that the APOL1 channel is permeable to Ca2+.
Testing for ion selectivity, we discovered that the ERev of APOL1-G0, the voltage
required to zero the current, was -6mV with a 2-fold cis:trans gradient of CaCl2
(Figure 7A). An ideal Ca2+ channel would have an ERev of -9mV in these conditions.
This was true for all three APOL1 variants tested (Figure 7B). While this
demonstrates the strong permeability of the APOL1 channel for Ca2+, it is in slight
contrast to its preferences for Na+ and K+, in which it behaves as an ideal cationselective channel (Thomson and Finkelstein, 2015). However, as the Ca2+ gradient
between the extracellular environment and cytosol is approximately 20,000-fold
(Clapham, 2007), a channel with even partial Ca2+ permeability can have large
effects on the cell.
The cation-selectivity of APOL1 remains controversial, however, as others
have suggested that it is Cl- selective. Cl- selectivity was first reported with a
truncated rAPOL1 (Perez-Morga et al., 2005), which was later proven to be nonfunctional, as it did not provide immunity against T. brucei in an HGD mouse
experiment (Molina-Portela et al., 2008). Cl- selectivity was also reported using KCl
loaded large unilamellar vesicles (LUVs), in which ionophore-mediated release of K+
from the LUVs was followed by Cl- efflux (Bruno et al., 2017). This Cl- selectivity only
occurred at pH 5.0 however, and they found that at pH 7.1 APOL1 was K+ selective.
While APOL1 may indeed be permeable to Cl-, it occurs at pH 5.0, where only a
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negligible current is recorded in planar lipid bilayers. Once neutralized however, the
current increases 450-fold (Figure 7A), and is driven by flux of cations. Therefore,
the proposed conductance of Cl- by APOL1 likely represents a leak. In contrast, the
evidence for APOL1 cation-selectivity is much stronger, due to its dissipation of Na+
and K+ gradients when overexpressed in animal cells or when added to
trypanosomes (Heneghan et al., 2015; Olabisi et al., 2016; Rifkin, 1984), the
inhibition of its toxicity in trypanosomes when sodium is replaced by larger and
APOL1-impermeant cations (del Pilar Molina-Portela et al., 2005), and the
selectivity studies performed using planar lipid bilayers (Thomson and Finkelstein,
2015).
We also report that APOL1 cytotoxicity is dependent upon extracellular Ca2+.
The cytotoxicity of APOL1 had a positive linear relationship with extracellular Ca2+
levels, and was significantly diminished by addition of EGTA or culturing cells in
CaCl2 free DMEM (Figures 7C and 7D). No effect on cytotoxicity was recorded by
increasing the amount of another physiologically relevant divalent cation, Mg2+
(Figure 8).
Utilizing high-throughput widefield microscopy in cells expressing the
cytosolic Ca2+ sensor GCaMP6f, we demonstrate that G1 and G2, but not G0, lead to a
Ca2+ influx that preceded cell swelling, membrane blebbing, and cell death (Figure
10, Movie 2). The Ca2+ influx recorded in FT293-G1 and G2 cells occurred gradually,
beginning 12-18h after induction of APOL1 expression, and continued to increase
even after swelling, which usually lasted another 12-18h before lysis. Lysis in this
experiment was delayed compared to when cytotoxicity alone was measured via
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LDH release (Figure 5C). This may be due to concurrent overexpression of GCaMP6f.
Importantly, the cell-impermeable DNA dye DRAQ7 was not detected until after
lysis, demonstrating that there is no large scale PM damage.
We next analyzed over 200 cells per genotype and condition from this
experiment using a Ca2+-dependent fluorescence threshold derived from uninduced
FT293-G0 cells. The threshold was designed to differentiate between cells that had a
large and sustained increase in Ca2+ over transient Ca2+ signaling. This highpowered analysis revealed that induction of G1 and G2, but not G0, led to a 4 to 5fold increase in cells above the fluorescence threshold (Figures 11D and 11E). While
we described an APOL1-driven Ca2+ influx in this study, another study reported no
changes in cytosolic Ca2+ in TREX293 cells (O'Toole et al., 2018). However, their
approach utilized the dye Fura-2 measured via fluorescent plate reader at a single
timepoint after induction of APOL1 expression, an experiment we performed
ourselves yielding similar results. However, using the brighter and genetically
encoded GCaMP6f and the much more sensitive technique of fluorescent
microscopy, combined with continuous analysis of hundreds of individual cells over
time, allowed us to observe the robust Ca2+ influx caused by G1 and G2.
Expression of APOL1 in the RUSH system allowed us to synchronize its
trafficking from the ER. We discovered that the cytotoxicity of RUSH-G1 and G2
required biotin-mediated release from the ER, and that LDH release started to occur
within 6h (Figure 12B). Interestingly, attempts to retain APOL1 in the ER using the
KDEL (luminal) or KKXX (cytoplasmic) retention signals failed (Figures 14A and
14B). As these signals are at the C-terminus where we hypothesize oligomerization
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occurs, perhaps they were inaccessible to the KDEL receptor and COPI and II
machinery responsible for ER and Golgi recycling (Dancourt and Barlowe, 2010).
We next utilized RUSH to demonstrate that the G1 and G2-mediated Ca2+ influx was
dependent upon trafficking from the ER in both HEK293 and CHO cells (Figures
12D, 12E, 12F, 15, 16, Movies 3 and 4). The same high-throughput analysis
performed in Figure 11D was applied to both HEK293 and CHO cells, revealing a 34-fold increase in cells above the respective Ca2+-dependent fluorescence threshold
(Figures 12G, 12H, 13B, and 13C). We also determined that the source of Ca2+ for the
APOL1-mediated influx is extracellular and not released from ER Ca2+ stores
(Figures 20 and 21, Movie 6). This was performed by co-transfecting RUSH-APOL1,
GCaMP6f, and the ER Ca2+ sensor ER-LAR-GECO into CHO cells. ER Ca2+ levels
remained steady or increased slightly concurrent to the cytosolic increase.
We next determined that APOL1 traffics to the PM within the timeframe of
Ca2+ influx first being recorded. Confocal microscopy revealed that RUSH-G0, G1 and
G2 led to robust and punctate staining at the cell surface 90min after biotinmediated release from the ER (Figure 17). Intracellular staining revealed RUSHAPOL1 co-localized with the ER marker calnexin. This co-localization was
diminished after 1 and 2h of biotin treatment, along with a concomitant increase of
APOL1 at the PM (Figure 18). Nearly all cells expressing RUSH-G1 and G2 were
swollen after 2h of biotin treatment, corroborating the phenotype observed in livecell microscopy experiments (Figure 16, Movie 4). Interestingly, the ER had receded
from its association with the PM in the swollen cells. A similar phenotype was
observed in human submandibular gland cells treated with a hypotonic solution,
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which caused a loss of ER:PM contact sites (Liu et al., 2010). These data support our
hypothesis that APOL1 traffics to the PM, whereupon G1 and G2 form cation
channels that lead to cell swelling and death. Our hypothesis corroborated by other
studies showing localization of APOL1 at the cell surface as well as overexpression
of APOL1 leading to a current across the PM (Heneghan et al., 2015; O'Toole et al.,
2018; Scales et al., 2017).
Finally, we discovered that RUSH-G0 could lead to cell death after
acidification and neutralization upon PM localization. As APOL1-G0, G1, and G2 are
all equally permeable to Ca2+ (Figure 7B) and have nearly identical channel forming
properties (Thomson and Finkelstein, 2015), the differences in cytotoxicity are
likely explained by differences in intracellular trafficking or interaction with a
putative chaperone. This result suggests that regulation along the secretory
pathway, where acidification occurs before neutralization at the PM, is what
prevents the cytotoxicity of G0. It has long been proposed that an SRA-like
chaperone may exist within the cell, possibly acting to prevent oligomerization as
SRA is hypothesized to do, or by altering the trafficking route of APOL1. A potential
chaperone was discovered in VAMP8, a SNARE protein that facilities vesicular fusion
(Madhavan et al., 2017). Surface plasmon resonance with truncated rAPOL1 (Cterminal residues 305-398) revealed that G0 binds to VAMP8, and that this
interaction is diminished with G1 and G2. However, no effects on G1 and G2
cytotoxicity were reported. It is important to continue this work to see what effect
acidification has on RUSH-G0 at the PM. We hypothesize that G0 arrives at the PM in
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mostly monomeric form, which will oligomerize and form channels after acid
treatment.
The cytotoxicity of APOL1 has been linked to various cell death pathways.
Overexpression of APOL1 stimulates autophagy. However, inhibition of this
pathway had no effect on toxicity, signifying that autophagy is a secondary effect
(Olabisi et al., 2016). APOL1 also activates the stress-activated kinase p38 MAPK,
and inhibition of this pathway sensitizes cells to sub-lytic doses of PFTs (Huffman et
al., 2004). Perplexingly, inhibition of MAPK rescued TREX293 cells from APOL1mediated cytotoxicity (Olabisi et al., 2016). Mitochondrial dysfunction has also been
proposed as a mechanism of APOL1-mediated cell death (Ma et al., 2017). We
believe this can be explained by two factors. First, the cells become swollen for
several hours prior to lysis, in a state of distress that likely affects mitochondrial
output (Figures 10, 15, 16, Movies 2, 3, and 4). Additionally, mitochondria can act as
a Ca2+ sink to regulate cytosolic Ca2+ levels. However, they can be overloaded by
uptake of too much Ca2+, leading to collapse of the mitochondrial membrane
potential and electrochemical gradient, leading to cell death (Rizzuto et al., 2012).
Mitochondrial dysfunction may therefore drive necrosis, but only acting
downstream of the APOL1-mediated Ca2+ influx.
APOL1 has also been linked to pyroptosis, a programmed necrosis pathway
that involves inflammasome activation leading to pore-formation by Gasdermin-D at
the PM (Beckerman et al., 2017). However, while pyroptosis is characterized by
driving ion fluxes across the PM, such as Ca2+ influx, there is also large-scale PM
damage detected via propidium iodide or Sytox Green nuclear staining prior to lysis
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(Chen et al., 2016; de Vasconcelos et al., 2018). In APOL1-mediated cell death there
is no nuclear staining by DRAQ7, a smaller cell-impermeant dye, until after the cells
have completely lysed (Figures 10 and 15, Movies 2 and 3), indicating that there is
no pore-formation by Gasdermin-D. Additionally, HEK293 and CHO cells lack the
necessary machinery to undergo pyroptosis unless components such as GasderminD are genetically introduced (Bast et al., 2014; Chen et al., 2016). It may be possible
that APOL1 initiates this pathway in pyroptosis-capable cell types such as podocytes
(Haque et al., 2016). Additionally, the NLRP3 inflammasome can be activated by an
increase in cytosolic Ca2+ (Lee et al., 2012b). With many pathways implicated in
APOL1-mediated cell death, however, it is hard to discern which, if any, is relevant
to disease, or if they all occur as downstream effects in response to APOL1 channel
activity.
The genetics of APOL1 and kidney disease are complex, as disease is caused
by a recessive mode of inheritance of proposed gain of function mutations
(Genovese et al., 2010). This allows for heterozygote advantage, where the carrier
has no disease risk but is protected against trypanosomiasis. We hypothesize that
the lack of disease in heterozygotes is due to two possibilities. First, that the
cytotoxicity of G1 and G2 is dose-dependent. This is because the majority of
homozygotes do not suffer from disease, indicating that G1 and G2 are typically well
tolerated. It is not until a second hit occurs, such as an HIV infection or prolonged
IFN treatment that disease manifests. Both of these events drive upregulation of
APOL1 expression (Nichols et al., 2015). Second, it is possible that G0 is a protective
allele. If there is an interaction with an SRA-like chaperone (Figure 23A), G0 may
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form dimers with G1 and G2 to prevent their cytotoxicity. Indeed, HEK293 cells
overexpressing transgenic G1 were partially rescued by CRISPR activator
upregulation of endogenous G0, however a mechanism has yet to be discovered
(Olabisi, 2017). It will be important to further elucidate the molecular
underpinnings of APOL1 heterozygote advantage in future studies to better
understand how the manifestation of disease.
This study has increased our understanding of APOL1-mediated cytotoxicity
and thereby its role in increasing kidney disease risk. Demonstrating that its
cytotoxicity is dependent upon channel formation at the PM should motivate further
research into blocking APOL1 channel conductance as a potential therapeutic,
rather than focusing on individual cell death pathways. Additionally, highlighting
the importance of acidification along the secretory pathway should lead to more
research on what possible regulatory mechanisms exist along this pathway that
differentiate the cytotoxicity of G1 and G2 from the non-toxic G0.
The limitations of this work are as follows. Co-transfection efficiency of
RUSH-APOL1 and GCaMP6f posed an issue, as not all cells analyzed expressed both
plasmids. We attempted to overcome this drawback by performing high-throughput
analysis. For the triple-transfection with ER-LAR-GECO, we did not perform the
high-throughput analysis, but rather analyzed cells that exhibited the established
phenotype of Ca2+ influx followed by swelling and lysis. To overcome the cotransfection issue in future experiments, a far-red fluorescent protein should be
cloned into the RUSH plasmid, or treatment could be performed with fluorescently
labeled biotin to distinguish transfected cells. For our high-throughput analysis, the
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threshold setting was based on manually measuring the ∆F/F0 of randomly sampled
control cells. Setting this threshold is integral to quantifying the large datasets, and
we aim to improve it by encompassing the data from all control cells to develop a
new method of threshold setting.
To complete the current study, the following experiments will be performed.
We hypothesize that the delays in cytotoxicity and initiation of Ca2+ influx by G1
compared to G2 (Figures 5C, 10, 11B, 15, 16, Movies 2, 3, and 4) are due to
differences in trafficking kinetics. In order to address this question, we will quantify
APOL1 signal at the PM as well as co-localization with the ER marker calnexin over
several time points from 0-2h of biotin treatment. To ascertain whether or not the
pH-gated cation channel of APOL1 directly conducts Ca2+ influx at the PM, we will
perform live-cell microscopy on cells co-expressing RUSH-APOL1 and GCaMP6f and
acidify the media after the Ca2+ influx is first detected. If modulating the pH halts the
Ca2+ influx, then this demonstrates that the APOL1 channel is directly responsible. If
not, then it suggests that APOL1 channel activity initiates a cascade of events that
leads to Ca2+ influx via a different mechanism. We will also perform this experiment
with RUSH-G0 to determine if it can initiate a Ca2+ influx after PM localization and
acid treatment. Additionally, the treatment of cells with EGTA to study the effects of
extracellular Ca2+ on cytotoxicity will be expanded to all three FT293-APOL1 lines.
Finally, as RUSH-G0, G1 and G2 all traffic to the PM after release from the ER (Figure
17), we will perform whole cell patch clamping. This will allow us to compare
channel activity between the variants by measuring the reversal potential of the
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current across the PM, and may provide insight about the lack of cytotoxicity with
G0 compared to that of the kidney disease variants.
To complement this study, future work will be aimed at identifying other
events leading up to APOL1-mediated cell death, using Ca2+ influx as a reference
point. APOL1 causes Na+ influx along with K+ efflux in both trypanosomes and
mammalian cells, which may also lead to membrane depolarization. Elucidating the
order of events will allow us to better understand the context of the Ca2+ influx and
determine what upstream event triggers cell death. Interestingly, it was reported
that rAPOL1 conductance of K+ required Ca2+ in the solution (Bruno et al., 2017). We
will assess what effects Ca2+ concentrations have on the APOL1 conductance of Na+
and K+. We are also interested in determining if an APOL1 chaperone or regulatory
mechanism exists along the secretory pathway. Finally, we aim to elucidate why
acidification is necessary for APOL1 cytotoxicity, and hypothesize that it leads to
oligomerization that is necessary for channel assembly.
In summary, we report that the cytotoxicity of APOL1 kidney disease risk
variants G1 and G2 requires trafficking from the ER, whereupon it localizes to the
PM. Acidification and neutralization along the secretory pathway allows for channel
formation at the PM and leads to a cytotoxic Ca2+ influx.
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Chapter 3
APOL1 and the Wound Healing Pathways
Introduction
Ca2+ activated wound healing pathways promote cell survival in the face of
PFTs and PM damage. Membrane that contains PFTs or has been damaged can
either be endocytosed and degraded or shed from the cell surface (Andrews et al.,
2014). Two independent repair pathways exist: lysosomal exocytosis followed by
membrane remodeling and endocytosis (Reddy et al., 2001; Tam et al., 2010), or
ESCRT-III mediated shedding (Jimenez et al., 2014; Scheffer et al., 2014). Both
pathways contain Ca2+ sensing proteins that mobilize and recruit the necessary
machinery to the wound site. As overexpression of APOL1-G1 and G2 leads to Ca2+
influx and membrane blebbing (Figures 10, 15, 16, Movies 2, 3, and 4), we
hypothesize that the cellular wound healing pathways are activated to promote cell
survival. Evidence of wound repair would provide further evidence that APOL1
forms Ca2+-selective channels that lead to cell death.
The protection offered by wound healing pathways is both temporary and
limited. Experiments highlighting the cell survivability provided by these pathways
are typically performed within 10min of PFT or Ca2+ ionophore treatment (Reddy et
al., 2001; Tam et al., 2010). Additionally, repair capacity can be overwhelmed by a
high dose of toxin, such as in the case of perforin (PFN). PFN is the pore-forming
protein utilized by cytotoxic T cells to deliver pro-apoptotic proteases (granzymes)
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to the target cell (Trapani and Smyth, 2002). PFN forms pores in the target cell
membrane, causing a Ca2+ influx that leads to a wound repair response that
endocytoses and delivers the granzymes. Recreating this phenomenon in vitro
requires careful titration of PFN concentration, otherwise the treatment will cause
necrosis (Keefe et al., 2005). These time and concentration-dependent limitations
require a more sensitive and fine-tuned approach to APOL1 overexpression. Here,
we demonstrate that inhibition of the ESCRT-III pathway sensitizes cells to APOL1.

Results
We first expressed APOL1 in FT293 cells with a pulse chase of doxycycline.
Rather than continuous exposure and overexpression of APOL1 as in Figure 5B, cells
were exposed to 1h of a lower amount of doxycycline followed by washing and a
23h chase. Additionally, as APOL1 leads to cell swelling for several hours prior to
lysis, we used the MTS assay, which requires reduction by a metabolically active cell,
to sensitize our readout of cell health prior to LDH release. Indeed, pulse chase
induction in FT293-G2 cells demonstrates the increased sensitivity in detecting
dying cells (Figure 24A), as a 1h pulse with 10ng/mL doxycycline led to 60% loss in
viability but only a 10% release of LDH. Next, we compared toxicity between 24h of
continuous APOL1 induction versus a 1 or 2h pulse. The 1 and 2h pulse led to a 50%
reduction in LDH release compared to 24h of continuous APOL1 expression, though
max LDH release was only 5-6%, and a 33 (0.64ng/mL doxycycline) or 80%
(3.2ng/mL) increase in viability. (Figures 24B and 24C). These results suggest the
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possibility that with low levels of G2 expression, the wound healing pathways
prevent further cell death.
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In order to determine if lysosomal wound repair is activated by
overexpression of G2, we tested for the presence of β-hexosaminidase, a lysosomal
enzyme, in the cell culture media. Treatment of CHO cells with 20µM and 40µM of
Ca2+ ionophore A23187 led to a 1.5 and 2.0% release of β-hexosaminidase,
respectively, (Figure 25A) without detection of cytosolic LDH, which correlates with
cell death (data not shown), indicating lysosomal wound repair activation. However,
treatment of FT293 cells with the ionophore led to a negligible release of βhexosaminidase that could not be explained by a low amount of enzyme within the
cell (Figures 25B and 25C). This was also observed in the non-stably transfected
HEK293 cell line (data not shown). This demonstrates that 293 cells are not
lysosomal wound healing competent, and are therefore unsuitable for studying this
pathway.
We next tested for the effect of ESCRT-III wound repair on APOL1
cytotoxicity. Importantly, ESCRT-III scission and disassembly requires ATP
hydrolysis by Vps4 (Alonso et al., 2016). Overexpression of Vps4bDN, which binds
to the complex but cannot hydrolyze ATP (Fujita et al., 2003), significantly
sensitized cells to UV-laser wounding (Jimenez et al., 2014). Accordingly, we
transfected FT293-G2 cells with Vps4b, Vps4bDN, and an empty vector 1d prior to
inducing G2 expression with a 1h pulse of doxycycline. We found that
overexpression of Vps4bDN led to a modest 20-30% increase of cytotoxicity when
G2 was induced with 10ng/mL of doxycycline (Figure 25D). As the effect was only
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observed with a higher amount of APOL1 expression, we then expressed G2 with
continuous doxycycline treatment for 24h. In these conditions, there was no effect
on cytotoxicity by Vps4bDN, likely due to the repair pathway being overwhelmed
(data not shown). These data suggested a modest role at best for ESCRT-III wound
repair. However, we next utilized the RUSH expression system for better temporal
control over APOL1 cytotoxicity.
The RUSH system allows us to control trafficking of APOL1 to the PM, where
wound repair occurs. We therefore co-transfected RUSH-G0 or G2 along with empty,
Vps4b, and Vps4bDN vectors in HEK293 cells and analyzed viability via the MTS
assay. Surprisingly, overexpression of Vps4bDN led to 30-40% loss in viability with
RUSH-G0 after 8 and 24h of biotin release (Figure 25E). No loss in viability was
recorded in cells co-transfected with RUSH-G0 and Vps4b WT or empty vector.
Additionally, RUSH-G2 with Vps4bDN led to a striking drop in viability even without
biotin treatment, as only 25-30% of the transfected cells were viable. As the RUSH
system is leaky (Figures 17A and 17C), this result suggests that the low amount of
G2 that gets to the PM is manageable (Figure 25E, G2-Vps4b WT without biotin) due
to ESCRT-III mediated shedding (Figure 26).
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Discussion
In this study, we demonstrate that ESCRT-III mediated budding promotes
cell survival against the cytotoxicity of APOL1. We utilized the MTS assay to
measure cell viability as a sensitive approach to complement LDH release. With a
pulse chase of APOL1 expression in FT293-G2 cells, cytotoxicity was modestly
increased due to Vps4bDN. The effect was much more pronounced with RUSH-G2,
where large-scale cell death was observed even without biotin-mediated release.
We reason that this is due to the leakiness of the RUSH system (Figures 17A and
17C). We also observed loss of cell viability with RUSH-G0 and Vps4bDN, further
supporting our hypothesis that ESCRT-III wound repair protects cells against
APOL1. Finally, involvement of lysosomal wound repair remains inconclusive.
The combination of pulse chase expression of APOL1 and the MTS assay
allowed us to fine-tune our assays. Use of the MTS assay allowed detection of APOL1
toxicity before cell death. This likely occurs for two reasons: APOL1 causes cells to
swell for several hours prior to lysis, likely affecting metabolic activity, and it has
been linked to mitochondrial dysfunction (Ma et al., 2017). The pulse chase
expression of APOL1 led to diminished cytotoxicity. While this is most likely due a
lower amount of APOL1 expression, the short burst of induction may also allow cells
to repair themselves.
Overexpression of Vps4bDN inhibits ESCRT-III mediated budding and
sensitizes cells to UV-laser damage (Jimenez et al., 2014). It also led to a modest
increase in cytotoxicity in FT293-G2 cells. The effect was only seen with pulse chase
expression of APOL1 and not with 24h of continuous expression. This is likely due to
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ECSRT-III only promoting survival for a short period time and against a low dose of
APOL1. Continuous overexpression of APOL1 will therefore overwhelm the modest
rescue. The temporal control of APOL1 offered by the RUSH system, on the other
hand, allowed us to fine-tune this assay further.
Co-transfection of RUSH-APOL1 with Vps4bDN significantly exacerbated the
cytotoxic effect of APOL1. This was especially striking with RUSH-G0, which is not
cytotoxic (Figure 12B) unless acidified and neutralized after reaching the PM
(Figure 22). This result suggests that, when overexpressed in the RUSH, a small
amount of G0 oligomerizes along the secretory pathway and forms channels at the
PM, but that those channels are shed from the membrane. Channel formation by G0
in this context is likely due to the synchronization of trafficking by the RUSH, where
the large build-up of G0 will traffic simultaneously through the secretory pathway,
possibly overwhelming any cell regulatory mechanism. With RUSH-G2, an increase
in toxicity was observed without biotin-mediated release of APOL1 from the ER. Due
to the leakiness of the RUSH system after 48h of transfection (Figures 17A and 17C),
there will be G2 at the PM even without biotin. This experiment demonstrates that
the ESCRT-III machinery can handle the relatively low amount of RUSH-G2 that
escapes the ER. In addition to these findings, we discovered that APOL1
overexpression can cause membrane blebbing (Figures 10, 11B, 15, 16, Movies 2, 3,
and 4), and another group reported APOL1 being shed by HEK293 cells into
microvesicles that contain the ESCRT-III protein ALIX (Taylor et al., 2014). Together,
these findings demonstrate a role for ESCRT-III in promoting cell survival against
APOL1 toxicity.
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As ESCRT-III is involved in several cellular processes (Alonso et al., 2016) it
is important to determine if its promotion of cell survival against APOL1 occurs at
the PM. In order to do this, previous studies utilized cells expressing CHMP4B, an
ESCRT-III protein that physically drives budding, fused with GFP. CHMP4B-GFP was
recruited the UV-damaged regions of the membrane (Jimenez et al., 2014). Coexpressing CHMP4B-GFP with RUSH-APOL1 will allow us to determine if it becomes
enriched at the PM after biotin treatment, and if there is an increase with untreated
RUSH-G1 or G2 compared to G0. Additionally, knockouts of the ESCRT-III recruiting
ALG2 and ALIX will further reveal the contribution of this pathway to promoting
survival.
Attempts at assaying for the presence of lysosomal wound repair were
unsuccessful. We were unable to use the FT293 cells due to lack of lysosomal
exocytosis after Ca2+ ionophore treatment. Additionally, attempts at finding the
lysosomal marker Lamp1 at the PM proved technically difficult in multiple cell lines.
We will assay for lysosomal wound repair using the RUSH system in cell lines that
are competent for this pathway. Additionally, SytVII and acid sphingomyelinase are
essential components of this pathway. Knocking out these genes sensitizes cells to
PFTs (Chakrabarti et al., 2003; Tam et al., 2010), and doing so with co-expression of
APOL1 will reveal if this pathway protects against APOL1 toxicity. However for this
current study, association between lysosomal wound healing and APOL1 remains
inconclusive.
The requirement of Ca2+ for wound repair and survival against APOL1 seems
paradoxical due to the Ca2+ dependence of APOL1 toxicity. Removal of extracellular
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Ca2+ leads to a significant increase in cell death when cells are treated with PFTs or
damaged by UV-laser (Jimenez et al., 2014; Reddy et al., 2001), but it also prevents
cytotoxicity by APOL1 (Figures 7C and 7D). It should be noted that in our
experiments we did not completely remove Ca2+ from the media due to the
contribution of 10% serum (Figure 7C), and doing so for long assays would be
lethal. Perhaps both scenarios coexist in a middle ground, with a minimum amount
of Ca2+ required to protect cells against APOL1. As APOL1 is also selective for Na+
and K+, it is likely cytotoxic even without extracellular Ca2+. In order to determine if
having no Ca2+ in the media will sensitive cells to APOL1, short-term experiments
will be performed with RUSH-APOL1.
In summary we present evidence that the ESCRT-III wound healing pathway
protects cells from APOL1 toxicity. This further supports our hypothesis that APOL1
forms Ca2+-permeable channels at the PM that lead to cell death.
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Summary
This study encompasses our attempts to elucidate the mechanisms
underlying APOL1 cytotoxicity and disease. We offer a mechanistic view of the steps
the kidney disease variants G1 and G2 require to kill a cell; Namely, trafficking along
the secretory pathway leads to channel formation at the PM, causing a cytotoxic
influx of Ca2+. We propose that the cation channel is the unifying event that leads to
all reported downstream inflammatory and cell death pathways, and that inhibiting
its activity should be the priority in the fight against APOL1-mediated kidney
disease. Our results suggest two possible targets for therapeutics: blockage of the
APOL1 cation channel, or inhibition of channel assembly. We hope that this work
will improve the understanding of how APOL1 leads to disease.
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Appendix
Digital Media
Movie 1. Validation of GCaMP6f function in FT293 cells (Figure 9).
Movie 2. Expression of G1 and G2 leads to Ca2+ influx prior to cell swelling in FT293
cells (Figure 10).
Movie 3. Expression of RUSH-G1 and G2 leads to Ca2+ influx, swelling, and lysis only
after release from the ER (Figure 15).
Movie 4. Expression and ER release of RUSH-G1 and G2 leads to Ca2+ influx and lysis
in CHO cells (Figure 16).
Movie 5. Validating the simultaneous use of GCaMP6f with the ER Ca2+ sensor ERLAR-GECO (Figure 19).
Movie 6. APOL1-mediated increase of cytosolic Ca2+ is not due to ER Ca2+ release
(Figure 21).
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